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Cytotoxicity of Multi-Purpose Solutions (MPS) is commonly tested on cells using diluted 
MPS or extracts from MPS soaked contact lenses.  There is evidence that lens type will affect 
uptake and release of compounds contained in MPS. To assess the cytotoxicity of agents 
contained in MPS that would be released by contact lens, an in vitro “onlay” model was used, 
whereby MPS soaked silicone hydrogel lenses were directly set onto a confluent monolayer of 
corneal cells. Chapter 4 describes the impact of MPS released from contact lenses on 
immortalized human corneal epithelial cells. MPS-soaked lens interactions with cells were 
characterized by studying cell viability, cell adhesion and caspase assays. In Chapter 5, 
mechanisms of cell death induced by exposure to MPS from contact lenses were determined 
through evaluation of apoptotic markers, such as activation of caspase 3 and 9. In Chapter 6, the 
impact of the physical properties of silicone hydrogel lenses, specifically surface treatments, on 
cytotoxicity of MPS were investigated.  The development of methods for characterizing the 
release of MPS from lenses, using absorbance spectra, is also described.   
The results indicate that exposure to contact lenses soaked in Opti-Free Express (OFX) 
and ReNu not only induces cell death in vitro, but also has an adverse effect on adhesion 
phenotype, suggesting that the remaining cells may have a compromised epithelial structure.  
Borate- buffered MPS were found to be more cytotoxic than phosphate-buffered base solutions. 
Investigation of the mechanisms of cell death revealed that ReNu and OFX induced corneal 
epithelial cell death in vitro using different pathways, whereby ReNu induced a necrotic pathway 
while OFX-induced cell death was mediated by the intrinsic pathway of apoptosis. The in vitro 
model was also able to identify differences between silicone hydrogels with different surface 
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treatments: the different surface treatments and chemistries of silicone hydrogels lens will affect 
the release profile of MPS and hence their potential cytotoxicity.    
By investigating the induction of cell death processes by solution-lens combinations in 
vitro, we aim to prevent potential adverse effects in the cornea, which may ultimately 
compromise various visual and barrier functions. The findings indicate the wealth of information 
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Corneal epithelial cell culture has been increasingly accepted as a valid tool for 
toxicology and biocompatibility studies.1-3 Many laboratories currently employ this model for 
drug screening and safety and for assessing ocular irritation.1-3 Most recently, cell culture models 
have been used to screen for the potential cytotoxicity of multipurpose solutions (MPS).  
MPS are single solutions, that are used to rinse, clean, disinfect, rewet and store contact 
lenses.4-7 MPS contain many different components to enhance disinfection and preservative 
properties. The disinfecting properties of MPS are conferred by the active biocide, which are 
commonly a polyquaternium, biguanide or hydrogen peroxide agent.8,9 The preservatives in 
MPS, such as Polyquad®, Aldox® and Polyhexamethylene biguanide (PHMB), are intended to 
breach cell walls of microbes, but may have the potential to cause corneal epithelial cell 
membrane toxicity.5,9-10 MPS also contain a buffering solution to maintain the pH of the solution, 
which is typically either borate or phosphate-based.9  
Silicone hydrogel (SH) lenses are the newest generation of contact lens materials, which 
incorporate siloxane moieties to increase the oxygen permeability to the cornea.11,12 The physical 
properties of siloxane allow for the potential adsorption and absorption of active components 
onto lenses while they are soaked in the cleaning solution, which then can be released onto the 
corneal surface during lens wear.8 While various surface modifications and proprietary chemistry 
are employed to reduce the hydrophobicity of the SH lens surface and the potential interaction of 
the lens with tear film components and active components of MPS11-13, it has been shown that 
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certain combinations of MPS and silicone hydrogel lenses can lead to a cytotoxic effect in vitro,5-
9, 15-17 and certain combinations (not necessarily the same as those that demonstrate problems in 
vitro) have the potential to exhibit corneal staining in vivo.14 With these observations, many 
biocompatibility studies have been undertaken to examine the effect of ophthalmic solutions, 
including contact lens packaging solutions and multipurpose solutions, on corneal and 
conjunctival cells.15-19 Many of these biocompatibility studies have used extracts or dilutions of 
the solutions to evaluate the corneal effect, or have used non corneal cell types as a proxy. These 
studies were able to evaluate the potential cytotoxic effect of ophthalmic and multipurpose 
solutions in vitro, and while this is valuable research, there is currently no information on the 
effect of the direct release of solutions from silicone hydrogel lenses on human corneal epithelial 
cells.  
This study was undertaken to determine the effect of the direct release of multipurpose 
solutions from silicone hydrogel contact lenses on corneal cell adhesion phenotype and viability. 
There is evidence that lens type will affect uptake and release of compounds contained in MPS.11 
Thus, to assess the cytotoxicity of agents contained in multipurpose solutions that would be 
released by contact lenses, a model whereby the contact lens was directly set onto a monolayer 
of corneal cells, was used.       
HYPOTHESIS 
The hypothesis of this research project is that borate buffer-based multipurpose solutions 
have a greater cytotoxic potential and induce more apoptosis in HCEC, compared to phosphate 
buffer-based solutions. We acknowledge from the literature that solution-lens incompatibilities 
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exist; thus we also hypothesize that lens properties affecting the release profile will also have an 
effect on the cytotoxicty of a solution. 
This thesis reports the results of in vitro experiments that were undertaken to verify our 
hypothesis. Before presenting the results, the structure and physiology of the cornea and 
mechanisms of wound healing and cell death are introduced in Chapter 2.  Chapter 3 presents a 
review on models and methodologies used to evaluate the cytotoxicity potential of multipurpose 
solutions. Chapters 4 to 6 report and discuss the experimental results for cell viability and 
adhesion phenotype (Chapter 4), mechanisms of apoptosis (Chapter 5) and lens effect (Chapter 





CORNEAL PHYSIOLOGY, WOUND HEALING AND CELL DEATH 
INTRODUCTION 
Preservation of vital corneal functions is essential to maintaining good ocular health. A 
compromised corneal epithelium could decrease the defence systems of the ocular surface, and 
increase the risk of serious infection.1,2 A “wounded” surface can also disrupt the refractive 
property of the cornea, compromising vision.3 The presence of cell adhesion molecules and the 
wound healing process in the cornea are essential to maintaining a healthy cornea when cell 
death and wounding occurs. 
STRUCTURE AND PHYSIOLOGY 
The cornea is a transparent avascular, non-keratinized epithelial structure, forming one-
sixth of the area of the outer wall of the eye.4-6 It represents the optical interface between the eye 
and external environment and functions as an optical element and protective barrier.3 Together 
with the lens, the primary function of cornea is to refract light to focus an image on the retina; 
therefore, they must maintain their transparency, optical physiology and structure.3 The corneal 
epithelium and the lens both originate from the surface ectoderm during embryonic 
development.3,7 
The normal human cornea is 500 µm thick and consists of 5 layers: corneal epithelium, 
Bowman’s layer, stroma, Descemet’s membrane and the corneal endothelial monolayer.8 The 
corneal epithelium is a stratified structure, 50 µm thick, consisting of a single layer of squamous 
superficial epithelial cells (SEC) several layers of intermediate wing cells, and a single layer of 
5 
 
columnar basal epithelial cells (BEC) (Figure 2.1).3,8,9 SECs range from 20-30 µm in length and 
are 5µm thick, while BECs are 10-15µm in diameter; wing cells can vary in size.8 Superficial 
corneal cells provide a substrate for the precorneal tear film, which acts as the primary refracting 
surface of the eye.10  
 
Figure 2.1: In vivo confocal images of the normal corneal epithelium.11  
Reprinted from Eye & Contact Lens. Bantseev V, McCanna DJ, Driot JY, et al . Biocompatibility of 
contact lens solutions using confocal laser scanning microscopy and the in vitro bovine cornea. Eye 
Contact Lens. 2007; 33: 308-316, with permission from Wolters Kluwer Health. 
 
The cornea is well protected from pathogens and the external environment by tight 
junctions and the constant self-renewal, lacrimation and blinking, antimicrobial enzymes in tears, 
and nearby antigens, cytokines, inflammatory mediators or leukocytes that enter the cornea via 
limbic and or ciliary body vessels.5,6,13 The population of epithelial cells is maintained by the 
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balance between cell divisions at the limbus and basal layers and cell loss or sloughing at the 
surface.6 After divisions, mature cells will migrate both centripetally and anteriorly, and flatten 
as they approach the surface. As older cells slough off into the tear film, the newly matured cells 
can be exposed.6 The epithelial cell turnover rate was found to be approximately 7 days in 
normal human corneas.14 Similarly, the turnover rate in mice is 6-7 days.15 The rapid epithelial 
renewal rate and continuous shedding of surface cells reduces the time and opportunity for 
mechanical stresses and potentially adherent and infectious organisms to contact the corneal 
surface.15   
The presence of tight junctions in the corneal epithelial layer plays a vital role in the 
barrier function of the cornea, protecting intraocular structures against diffusion of substances 
from the tears, transport of ionic or polar molecules, microbial infections and other 
environmental stresses.10,12 Tight junctions (Figure 2.2) are formed from two integral 
transmembrane proteins, occluding and claudins, and several membrane associated proteins, ZO-
1, ZO-2 and ZO-3. ZO-1 is localized in the apical region of SECs cell-cell junctions.2 In rabbits, 
however, ZO-1 is distributed in the BEC and wing cells.2 
Like tight junctions, gap junctions occur between adjacent cells (Figure 2.2). They are 
membrane channels that allow for the flow of ions and small molecules between adjacent cells.16 
These hexametric channels are composed of connexons, which can attach to connexons in the 




Figure 2.2: Types of cell-cell and cell-ECM junctional complexes, which facilitate adhesion and 
communication in corneal cells. A. Diagrammatic representation of tight junctions, gap junctions 
and other cell adhesion complexes. B. Electron micrograph of tight junctions (TJ) and 
desmosomes (D) in an ultrathin section of Epon-embedded MDCK cells.17 C. Electron 
micrograph of self assembled gap junctions.18  
A. Reprinted with permission from Dr. Danton O’Day. 
B. Reprinted from Invasion and Metastasis. Huber D, Balda MS, Matter K. Transepithelial migration 
of neutrophils. Invasion Metastasis. 1998; 18: 70-80, with permission from S. Karger AG, Basel. 
C. Reprinted from Microscopy and Research Techniques. Kistler J, Evans C, Donaldson P, et al. 
Ocular lens gap junctions: protein expression, assembly, and structure-function analysis. Microsc 
Res Tech. 1995; 31: 347-56, with permission from John Wiley & Sons. 
 
The cornea also contains integrins, which are a family of cell surface receptors.19,20 There 
are at least 9 unique beta subunits and 24 alpha subunits, which can associate non-covalently in 
multiple combinations as a heterodimer.19,20 They are characterized by a large extracellular 
domain, an alpha-helical transmembrane domain and a cytoplasmic domain (Figure 2.3).19,20 





structures and maintenance of tissue integrity.19-22 The association of integrins with various 
extracellular matrix proteins, including fibronectin, vitronectin or laminin, as a ligand, allows 
integrins to carry out these functions, such as in cell migration where integrins transmit forces 
from the matrix to the cytoskeleton and regulate changes in cytoskeletal organization.19,20 Many 
adhesive proteins, such as fibronectin and vitronectin, contains an RGD sequence, which serves 
as a cell attachment site where many integrin families and extracellular matrix molecules can 
bind to.19,23 
 
Figure 2.3: Basic structure of integrin heterodimer on cell surface. 
Reprinted with permission from Dr. Danton O’Day. 
There are several different integrins key to cell adhesion and wound healing processes of 
the cornea.  The most relevant are described below and Table 2.1 lists all ocular integrins, which 
play a role in cell adhesion, cell cycle regulation and wound healing in the cornea. 
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- α3β1 is important in cell migration as it regulates the expression of matrix 
metalloproteinases responsible for cell movement and spreading.  It is also important 
in the maintnance of cell-cell junctions and hemidesmosome stability.19,21 
- α6β4 is a cell survival factor.11 Like α3β1, it regulates cell cycle progression.19 
During cell migration, this integrin is phosphorylated to prevent premature 
reassembly of hemidesmosomes.19 It is also a strong component of 
hemidesmosomes.19-21  Expression of this integrin is crucial for stable adhesion of the 
epithelium to the basement membrane.19 Knockout studies in mice have found that 
the absence of β4 results in defects in epidermal adhesion and the assembly of the 
basement membrane.19,24 Low levels of these important integrins results in a 
disruption of cell adhesion.19,24 
- α5β1 is an important part of the wound healing process.25  Healthy, actively migrating 
cells will express α5β1, which will increase the sensitivity to fibronectin, which can 
act as a chemotatic migratory stimulus.25 
- α9β1 is localized only in the corneal epithelium and also plays an important part in 
the wound healing process.19 α9 regulates the association of proteins with the 
cytoskeleton to aid in cell migration.19 It is especially important in sustaining cell 
migration once it has been inititated.19  
- αvβ6 is another important integrin in the wound healing process and in cell 
migration.19 The expression of this integrin during wound healing helps to maintain 
the integrity of the tissue.19 It also is a regulator of E-Cadherin expression.19 Loss of 



















































































































MECHANISM OF WOUND HEALING  
Corneal wound healing occurs in three phases.26-29 Upon epithelial injury, such as corneal 
lesions caused by continued inappropriate contact lens use, fibronectin will accumulate at the 
injury site from dilated conjunctival vessels in the first, slow phase of wound healing.25-29  
Healthy cells 50-70 μm from the wound edge will start to disassemble their 
hemidesmosomes.19,20 The presence of fibronectin, peaking between 3 and 12 hours post injury, 
is found to be both chemotatic and haptotactic, and will act as a migratory stimulus for these 
newly detached cells.19,26,28 Fibrin together with fibronectin will fill the wound bed and act as a 
hemostatic plug to prevent any further blood loss from deep scrape wounds.30 The actively 
migrating cells will express α5β1, which increases the sensitivity to fibronectin.28,29 Chemotactic 
signals allow the healthy cells to migrate in a “sliding motion” into the provisional matrix 
(Figure 2.4) and will enter the rapid, second phase of wound healing upon proliferation.20,27-30 
During this phase, cell number increases and thickness of epithelium returns to normal.29 The 
third phase is the consolidating phase.27 Differentiation occurs to establish a well layered 
epithelium.29 New matrix proteins are synthesized to replace what was lost or damaged.30  
 
Figure 2.4: Migration of epithelial cells in wound healing, mediated by cell extension by actin 
polymerization and integrins binding to fibronectin. Reprinted with permission from Dr. Danton O’Day. 
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MECHANISMS OF CELL DEATH 
Apoptosis is a programmed form of cell death that has been evolutionarily conserved 
among multicellular organisms.31-34 It plays a role in several normal physiological process such 
as embryonic development, tissue homeostasis, and self-organizational processes in the immune 
system and central nervous system.33-35 It also serves as a defence mechanism in its role of 
removal of damaged cells.33-35 This form of cell death has several morphologically recognizable 
features, including cytoplasmic shrinkage, plasma membrane blebbing, compaction of nuclear 
chromatin formation of vesicles and apoptotic bodies, and rapid cleavage of DNA into 180bp 
fragments, corresponding to internucleosomal spacing.33,34 There are two, possibly three, distinct 
molecular signalling pathways that lead to apoptotic cell death: the extrinsic or extracellularly 
activated pathway and the intrinsic, mitochondrial mediated pathway (Figure 2.5).32 Both 
signalling pathways involve cysteine aspartate proteases (caspase), which act as mediators for 
initiating cellular disassembly.32,34 Caspases are initially translated in an inactive precursor form, 
containing two subunits (one large and one small) and a prodomain.33,34 In order to become 
active and cause apoptosis, they must be cleaved at aspartate residues and assembled into 
heterotetramers.34,36-38 Upon activation, caspases will cleave select substrates at aspartate 
residues to enhance or inhibit activity of pro-apoptotic or anti-apoptotic proteins and enzymes.34 
The ability to cleave at aspartate residues suggests that caspases act on themselves or other 
caspases in a hierarchal cascade.33 Activated effector caspases can act on substrates to induce 
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Figure 2.5: Flow chart of apoptotic events in the extrinsic and intrinsic pathways. 
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The extrinsic pathway differs from the intrinsic pathway, in that it involves the binding of 
ligands, such as TNF-α or Fas, or viruses, to death receptors on the cell surface to initiate a 
tyrosine phosphorylation cascade.32,35 The cascade can stimulate death domains and trigger the 
activation of procaspase-8.32  
The intrinsic pathway is activated within the cell in response to cell stress or cell damage, 
such as UV radiation, osmotic shock, deprivation of growth factors, or exposure to toxic agents 
(i.e. chemotherapeutic drugs or cytotoxic components of multipurpose solutions released from 
contact lenses).35 One of the early events of the intrinsic pathway of apoptosis is alteration of 
mitochondrial transmembrane potential.32,35,39,40 When apoptotic stimuli disrupt the 
mitochondrial transmembrane potential, it triggers the release of cytotchrome c (cyt c) from the 
intermembrane space, leading to activation of C9 and intrinsic activation of apoptosis.34,35,39,40 
Cyt c in the cytoplasm can bind Apaf-1 (apoptotic protease activating factor-1), a scaffolding 
molecule key to the formation of the apoptosome.34,41 Cyt c will induce a nucleoside 
triphosphate-dependent conformational change, allowing for the binding of procaspase-9.42-47 
Procaspase-9 is the initiator caspase of the intrinsic pathway of apoptosis.48,49 It is a monomer 
with misaligned catalytic cysteine and histidine residues and an inactive catalytic pocket.48,49 The 
complex of cyt c, Apaf-1 and procaspase-9 forms the apoptosome, which leads to the activation 
of C9 by conformational changes that open the catalytic pocket and align the catalytic residues. 
At this point, the intrinsic and extrinsic pathways merge, as both C8 and 9 have the ability to 
proteolytically activate C3.32  
As one of the effector caspase, C3 is responsible for mediating characteristic 
morphological and biochemical changes, by cleavage of several hundred different substrates.37,38 
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Cleavage of these substrates will either favour pro-apoptotic activity or inhibit anti-apoptotic 
activity.37 Cytoplasmic blebbing is caused by cleavage and activation of gelsolin, which severs 
actin filaments.37,38 C3 also cleaves several intermediate filament proteins, including lamin B, 
nuclear/mitotic apparatus protein (NuMA) and cytokeratins.37,38 These proteins in their normal 
state are responsible for the maintenance of cell shape, and cleavage contributes to 
destabilization of the cell structure and additional apoptotic morphological changes.37,38 In the 
late phase of apoptosis, C3 cleaves the nuclease inhibitor, ICAD (inhibitor of caspase-activated 
deoxyribonuclease), resulting in the internucleosomal cleavage of DNA, by the enzyme CAD.50-
52 Inactivation of ICAD by C3 cleavage leads to DNA fragmentation.50-52 C3 also activates a 
phospholipid scramblase, by cleavage of protein kinase Cδ.53-57 The activated phospholipid 
scramblase catalyzes the transfer of phosphatidylserine (PS) from the inner leaflet to the outer 
leaflet of the plasma membrane.53-57 This provides a signal that can be recognized by the adaptor 
molecule MFG-E8 on adjacent cells and/or a PS receptor present on macrophages, facilitating 
phagocytosis of the dying cells.53-56 
Necrosis is a form of cell death considered to be accidental or inappropriate, which 
occurs under extremely unfavourable conditions.58 It is an uncontrollable, irreversible form of 
cell death characterized by cell swelling, membrane deformation and organelle breakdown.58 It 
has not been determined whether signalling pathways mediate necrotic cell death.58 
CONCLUSION 
Understanding the mechanisms of wound healing and physiology of the cornea help 
emphasize the importance of preventing corneal cell death. By investigating the induction of cell 
death processes by toxic agents, we strive to prevent adverse effects in the cornea, which may 
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compromise visual and barrier functions. Research in this field must consider these mechanisms 







OCULAR CYTOTOXICITY TESTING METHODS OF MULTIPURPOSE SOLUTIONS 
1. INTRODUCTION  
When ocular complications caused by ‘Lash Lure,’ a cosmetic eyelash dye, were made 
public, it became apparent that a rigorous procedure for ocular testing was needed to evaluate the 
irritant or corrosive properties of a substance before marketing it as a product.1 In the early 
1940’s, John Draize started to develop a system, which would quantitatively assess the toxicity 
of topical compounds for cutaneous and ocular use.1 His methodology involved assessing the 
acute, intermediate and chronic exposure, by applying compounds to the skin, penis and eyes of 
rabbits. The biological responses were graded according to an established descriptive scoring 
scale, to determine the effects on the eye and skin. Draize described his methods as a 
‘toxicologic appraisal of a given compound or preparation intended for therapeutic, cosmetic or 
other topical use’.1 With observations from the Draize test, it was possible to estimate the 
amount or concentration and frequency of use of application that would be safe to and tolerable 
by man.1 These methods soon became considered, by the FDA, as one of the most valuable and 
reliable methods for evaluating the hazard and safety of a substance introduced into or around 
the human eye.1 
One such substance is contact lens care disinfection systems. Before and after lens wear, 
contact lenses must be disinfected to prevent growth of harmful bacteria that may be present on 
the lens and remove lipid and/or protein deposits on lenses.2-5  One of the most commonly 
prescribed disinfection systems is multi-purpose solutions (MPS).4-6 MPS are single solutions, 
that contain a preservative (antimicrobial agent) and other components, that are used to rinse, 
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clean, disinfect, rewet and store contact lenses.2-5 The ideal solution must be efficacious enough 
against a wide spectrum of microbial flora, but gentle enough to not cause adverse effects on the 
corneal surface, as some of the solution will be exposed to the corneal surface and remain in 
contact with the epithelium until washed away by the tear film.4-6  The preservatives in MPS, 
such as Polyquad®, Aldox® and Polyhexamethylene biguanide (PHMB), are intended to breach 
cell walls of microbes, but may have the potential to cause corneal epithelial cell membrane 
toxicity.3,7 It is thought that the disinfecting agents cannot penetrate the surface of the lens, due 
to their high molecular weight, but one cannot ignore the potential of the lens to adsorb or form a 
complex with components of MPS and release them onto the corneal surface post insertion.4 
Because of the potential exposure to the cornea and the high frequency of use, MPS must also be 
subject to ocular cytotoxicity testing.8,9 
The cornea is an avascular, multilayered structure, which serves as the optical interface and 
protective barrier between the eye and external environment (physiology and mechanisms of cell 
death were described in Chapter 2).10-12 A disturbed surface can disrupt the refractive property of 
the cornea, compromising vision.13 A compromised corneal epithelium could also decrease the 
defence systems of the ocular surface, and increase the risk of serious infection14,15 and it is thus 
important to assess the potential cytotoxicity of contact lens solutions.  
Over the years, many methods of testing for ocular toxicity have emerged as modifications or 
alternatives to the Draize test. While whole animal testing still exists, isolated tissue and tissue 
culture models have been widely used to screen for ocular toxicity. This review will discuss the 
whole animal studies used to assess the cytotoxicity potential of MPS, and the isolated tissue and 
tissue culture approaches, and assays, developed as more ethical, objective and sensitive ocular 
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toxicity screening procedures. Table 3.1 lists the all of the marketed contact lens solutions tested 
in the studies discussed in this review, their chemical composition and highlights the evolution of 
MPS formulation. Table 3.2 lists the family of surfactant agents commonly found in 
multipurpose solutions 
Table 3.1: Chemical composition of multipurpose solutions.  

































































































WHOLE ANIMAL STUDIES 
Applications of the Draize test have been used to study the cytotoxicity potential of 
commercially available contact lens solutions.  Many studies have quantified the effects of soft 
contact lens solutions on rabbit corneal epithelium. In these studies, NZW rabbits were fitted 
with contact lenses, which were soaked in test solutions. Assays were performed immediately 
following lens removal. In some studies, the nictitating membrane was partially excised 1 week 
prior to the start of the experiment.8 The nictitating membrane is a transparent third eyelid found 
in birds, reptiles, fish and some mammals, including rabbits.16 It functions primarily for 
protection and to moisten the eye. In contrast to human eyelids, the nictitating membrane is 
drawn across the ocular surface horizontally.16 In removing this membrane, the results were more 
generalizable to humans.1 
Begley et al2 were one of the first groups to use the Draize test to screen for ocular irritancy. 
They examined 3 different solutions: ReNu multipurpose disinfecting solution (0.00005% 
PHMB), Opti-Free rinsing, disinfecting and storage solution (0.001% Polyquad®), and AOSEPT 
(dilute hydrogen peroxide). Results from Scanning Electron Microscopy (SEM) demonstrated 
corneal alterations induced by all three solutions. AOSEPT and Opti-Free showed an increase in 
both the number of wrinkled and peeling cells. Peeling cells refers to cells that have lost their 
desmosomal attachments, therefore, appearing to peel away from epithelial surface.2 Exposure to 
ReNu caused the greatest increase in wrinkled and peeling cells.2 The intact cells that remained 
showed few holes and flattened microplicae, indicating exposure of the underlying layer. All 3 
experimental solutions showed a significant treatment effect compared to the saline controls, 
which indicated that it was likely the preservative, residual unneutralized hydrogen peroxide, or 
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other additives that were responsible for the surface effects.2 It was suggested by the authors that 
the increased toxic effect of ReNu may be attributed to the preservative, PHMB. These results 
suggested that PHMB was not only cytotoxic, causing cell death, but also had the potential to 
cause exfoliation or peeling of the superficial epithelial layers.2   
Interestingly, another rabbit study did not find as strong of a cytotoxic effect with ReNu, but 
still could attribute epithelial damage to PHMB. Chang et al evaluated the corneal response using 
in vivo confocal microscopy and tear lactate dehydrogenase (LDH).8 In vivo confocal 
microscopy was able to provide a non-invasive assessment of the cornea at the cellular level.8 A 
specific technique, confocal microscopy through focusing, captured an extended focus, with 
continuous, confocal optical sectioning of the cornea in the coronal plane through the entire 
thickness.8 This approach provided both a 3D view of the cornea and accurate, and repeatable 
measurements of the corneal epithelial and stromal thickness.8 To have more precise 
measurements of the epithelial thickness, several scans through just the corneal epithelium were 
taken. Tear LDH activity, an indicator of epithelial cell damage,17 was determined using 
spectrophotometry, with a modified rate assay. The optical density of the reaction mixture was 
read at 340nm at 1 minute intervals, on a UV spectrophotometer. Confocal microscopy revealed 
that epithelial thickness showed a tendency to decrease with contact lens wear.8 All-in-One 
showed a significant decrease in the central cornea, while Opti-Free showed a significant 
decrease in the peripheral cornea. All-in-One also showed a significant decrease in epithelial cell 
area, in the central cornea. Unisol significantly decreased the epithelial thickness in all areas of 
the cornea.  All-in-One and Unisol also had a significant effect on LDH activity; a 152% and 
308% change over time, respectively, was observed. Opti-Free and ReNu did not show any 
significant change over time.8 The preservatives were discussed as being the agent responsible 
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for the solution difference.8 While previous studies reported that PHMB at 0.00005% had no 
effect on cytokinetic movement or mitotic activity of cultured HCEC, the effect of PHMB here 
may be due to the 10 fold increase in concentration. All-in-One, which significantly affected 4 of 
the 7 parameters evaluated, has a PHMB concentration of 0.0005%. ReNu, with a PHMB 
concentration of 0.00005% (10x lower than All-in-One), did not significantly affect any of the 
parameters tested. The increased concentration of PHMB may be the source of the difference 
between All-in-One and ReNu, and account for the corneal damage.8 Opti-Free only significantly 
affected one parameter, indicating that the preservative, 0.001% Polyquad®, did not have a 
significant effect on the cornea at this concentration. 
Researchers using a rat animal model also made similar conclusions about the Opti-Free 
preservative, Polyquad®, and suggested it as an alternative preservative to Benzalkonium 
chloride (BAK).7 Male Lewis rats received eye drops of 0.1% or 0.5% Polyquad twice daily for 
11 days. A higher than normal concentration of Polyquad® was used, as lower concentrations 
did not yield detectable effects on the rat corneo-conjunctival surface in preliminary studies.7 
The results reported that 0.1% and 0.5% Polyquad® produced slight, but not significant, 
decrease in tear production (as measured by the phenol red thread test), whereas 0.5% BAK did 
have a significant effect.7 Polyquad® induced occasional punctate staining, but the slit lamp 
examination revealed no abnormalities. Confocal microscopy and impression cytology revealed 
cells exposed to 0.1% Polyquad® had good sheets of normal, polygonal cells, but did observe a 
significant decrease in goblet cells when exposed to 0.5% Polyquad®, compared to control eyes. 
Goblet cells are responsible for producing soluble mucins that form the mucous layer of the tear 
film.7 The loss of goblet cells is considered an indicator of ocular surface diseases, not limited to 
dry eye syndromes.  The authors conclude that Polyquad® showed little toxicity, especially in 
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comparison to BAK and that the rat model was able to reproduce the mechanism of toxicity due 
to preservatives.7  
Overall, several trends have emerged from animal cytotoxicity testing. Opti-Free 
(Polyquad®) generally showed little cytotoxicity, and was one of the safest solutions studied. 
Increasing concentrations of PHMB were correlated to increasingly adverse effects on the 
corneal surface. The scale of toxicity derived from these studies is generally that OFX < ReNu < 
All-in-One (Polyquad® < PHMB 0.00005% < PHMB 0.0005%). 
While animal studies are still the model of choice, one must consider that numerous 
physiological factors, such as lower tear production and ocular surface sensitivity, and 
anatomical and biochemical factors, such as nictitating membranes, genus-specific tear film 
components, and thinner corneas lacking a Bowman’s layer, limit its relevance to humans.1 In 
fact, only a few studies have used rabbit models to screen for ocular toxicity. Many of these 
studies, including the Draize test, have been opposed because of ethical concerns arising over the 
pain and discomfort associated with the potentially harmful materials being placed directly on 
the ocular surface.1, 13, 17,18 Animal studies have also been criticized due to poor repeatability, 
poor sensitivity and lack of objectivity.1, 13, 17, 18  This has prompted the development of in vitro 
assays using intact organs (here to be referred as isolated tissue) or tissue culture techniques to 
test for potential ocular irritation. 
2. ISOLATED TISSUE 
a. BOVINE LENS CULTURE SYSTEM 
Bovine eyes can be obtained from an abattoir after animals are killed for human use (i.e. 
meat) or have reached the end of their useful life (i.e. those raised for milk production).19 The use 
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of (abattoir supplied) cultured bovine crystalline lenses was one of the first in vitro alternatives 
to the Draize test.20 It is a good proxy for the cornea due to a number of common features such as 
the common origin from surface ectoderm, gene sharing and common appearance of crystallins 
and water soluble proteins.13, 21 When the lens is excised and cultured, it is able to maintain its 
cellular makeup and refractive function, whereas corneal epithelial cells do not.13 The advantage 
of the lens culture system is that the intact lens retains repair mechanisms, an important aspect of 
the Draize test that has been difficult to model using in vitro systems.13 
In the lens culture system, one can evaluate the toxicity of a substance based on how it 
affects the optical quality of the lens. One of the parameters that can be measured is the 
variability in the Back Vertex Distance (BVD). BVD refers to the ability to have a sharp focus; 
as there is more variability in the BVD, focus is lost (Figure 3.1).13 BVD variability has been 
correlated to corneal opacification.13 Following treatment with a toxic agent, mitochondria can 
be affected, making the lens more permeable to oxygen. As oxygen starts to permeate to the core 
of the lens, opacifications can form, altering the optical quality of the lens, thereby affecting 






Figure 3.1: Graphic profile of the lens focal variation as seen in an untreated bovine lens (A) and a bovine 
lens treated with benzalkonium chloride extract (B).22 
Reprinted from Eye & Contact Lens. Dracopoulos A, Dixon DG, Jones LW, et al. In vitro assessment of 
medical device toxicity: interactions of benzalkonium chloride with silicone containing and p-HEMA-
containing hydrogel contact lens materials. Eye Contact Lens. 2007; 33: 26-37, with permission from 
Wolters Kluwer Health. 
  
In looking at rigid contact lens solutions, Sivak et al18 were able to determine that the lens 
culture system was sensitive enough to detect toxicity potential. The study tested several contact 
lens solutions, which were added directly to the culture, with enough to expose both surfaces of 
the lens. After the exposure time, a scan was performed to measure focal length, to evaluate focal 
variability (BVD) and optical function. Toxicity in this study was again attributed to the 
preservative PHMB.18 The least toxic solution, the newest formulation of Boston Advance 
Conditioning solution at the time, had a 3 fold decrease in PHMB concentration compared to the 
most toxic solution.  
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While the Sivak study looked at rigid contact lens solutions, the lens culture system has also 
been used to evaluate toxicity potential of soft contact lens care solutions. In a 2006 study, by 
Oriowo et al,4 bovine lenses were exposed to undiluted MPS, Opti-Free Express, ReNu 
MultiPlus or Complete Comfort Plus, for 3 hours. The optical changes of the lens were measured 
using a resazurin (alamarBlue) assay. Resazurin (alamarBlue) dye quantifies living cells using 
resazurin and resorfin, as a fluormetric-colorimetric indicator that fluoresces and changes colour 
in response to reduction.4 The oxidation-reduction reaction involving resazurin and resorfin 
indicates cell metabolism; therefore, viability can be quantified. Fluorescence was measured at 
baseline and at several other time points post exposure, up to 96 hours. The results found that 
Complete did not show any changes in fluorescence profile during the time course. At 6 hours, 
Opti-Free and ReNu showed significant cytosensitive effects. Opti-Free had a significant 
recovery at 12 hours, but again had a significant toxic effect at 24 hours, before recovery once 
more at 96 hours. ReNu, however, showed no recovery at 12 hours, but had a gradual recovery to 
baseline levels by the end of the study. From the results, the authors determined a scale of 
cytosensitivity where, Complete < ReNu < Opti-Free (0.0001% PHMB < 0.001% Polyquad®, 
0.0005% Aldox®).4  
This trend is different than that observed in the animal studies. While the preservative is still 
considered the cytotoxic agent, PHMB which was previously considered a toxic preservative, 
showed little to no toxicity in ReNu and Complete. While both solutions use PHMB, the 
molecular weight of PHMB may differ between the solutions. Cytotoxicity may be accounted for 
by this potential difference, as cells of different ocular origin may be susceptible to polymers in a 
particular size or molecular weight range. Contact lenses may also interact differently with 
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polymers of different molecular weight, which may affect the amount adsorbed and subsequently 
released onto the corneal surface.  
The Polyquad®-containing Opti-Free solution was the most cytotoxic.4 Polyquad® was 
hypothesized as the source of the cytotoxicty, where previously it had been found in the rat 
model to be much safer than BAK, and proposed as a safe preservative to replace BAK.4,7 One 
must consider the different model systems (rat whole animal vs. isolated bovine culture) as a 
potential source for the contrasting observations about Opti-Free and Polyquad®.  
b. WHOLE CORNEA EXPLANTS 
Bovine corneas have been shown to have a similar appearance to rabbit and human corneas, 
after a rigorous washing procedure.19 While it has more epithelial layers compared to a human 
cornea, bovine corneas show the same organization as mammalian corneas.19 This culture 
system, in addition to the lens culture system, is a good alternative to the use of laboratory 
rabbits. One of the more recent MPS toxicity studies used corneal buttons obtained from bovine 
eyes to assess the effects of two contact lens solutions, ReNu and Opti-Free Express, using 
confocal laser scanning microscopy.21 Intact corneas were exposed to 2mL of undiluted test 
solution for 30 minutes at room temperature. Corneal buttons were excised and stained with 
rhodamine 123, a mitochondrial specific dye, and the nuclear specific dyes, YO-PRO-1, which 
aided in the visualization of the nuclei and identified apoptotic-related alterations in the nuclear 
membrane, and propidium iodide, which identified necrotic cells. Confocal microscopy was used 
to visualize specific dye fluorescence and a MatLab program was used to characterize properties 
of the mitochondria. Following treatment with Opti-Free Express, a significant decrease was 
observed in the number of mitochondria in the superficial and intermediate epithelium when 
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compared to cornea exposed HBSS control or ReNu. ReNu also showed a decrease in number of 
mitochondria in the superficial epithelium. The observed change in mitochondria suggested that 
treated cells were undergoing a metabolic change in cell function.21 The authors proposed that 
the assay used in this study can be used as a screening tool to compare the depth of formula 
penetration and detect early cellular changes that may indicate ocular irritation. Opti-Free can be 
considered as having a greater depth of formula penetration compared to ReNu and HBSS 
controls.21 
Porcine corneal models have also been recently proposed as a means to evaluate MPS 
cytotoxicty.6 A 2009 study used both isolated tissue and tissue culture approaches to evaluate the 
corneal response to Opti-Free RepleniSH, ReNu and Complete. 6 Fluorescein staining and flow 
cytometry were used to evaluate the potential toxic effects. Excised globes were directly 
immersed in one of the test solutions for 5 or 10 minutes. Integrity of the corneas was graded on 
the Efron scale, from 0 (no staining) to 4 (severe staining), after instillation of fluorescein.6 The 
globe was then carefully dissected, to dissociate corneal cells for flow cytometry.  There was 
only a significant increase in grading scores at the longer time point compared to controls, and 
fluorescein staining did not show differences between solutions. In contrast, cytotoxic effects 
were detected by flow cytometry in as little as 5 minutes with Opti-Free RepleniSH. Similar 
results were observed with the tissue culture approach. Cell suspensions were incubated with one 
of the test solutions, and it was observed that the greatest amount of fluorescein staining, and 
evidence of early and late necrosis, was in cells suspended in Opti-Free RepleniSH. The use of 
both flow cytometry and fluorescein staining approaches allows for the direct comparison of 
these two assays as accurate measures of cytotoxicity. As shown in Figure 2, it was found that 
fluorescein staining in this model was not as sensitive to detect corneal damage, as flow 
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cytometry.6 The results from this study indicate that fluorescein staining does not correlate well 
with cytotoxicity (Figure 3.2).6  
 
Figure 3.2: Cytotoxicity effect on (a) 30 s, (b) 1 min, (c) 5 min, and (d) 10 min soaked in Opti-Free 
RepleniSH using FCM and fluorescein staining. (D1: amount of 7-AAD stained cells—early necrosis; 
D2: amount of Annexin V-FITC + 7-AAD stained cells—late necrosis; D3: amount of non-stained 
cells—healthy cells; D4: amount of Annexin V-FITC stained cells—apoptosis.6 
Reprinted from Optometry and Vision Science. Choy CK, Cho P, Boost, MV, et al. Do multipurpose 
solutions damage porcine corneal epithelial cells? Optom Vis Sci. 2009; 86: 1-7, with permission from 
Wolters Kluwer Health.  
 
The observed cytotoxicity was attributed to the presence of Polyquad in Opti-Free 
RepleniSH. It was also mentioned that other constituents have been shown to have cytotoxic 
potential, but since this study tested the whole solution, and not individual components, the 
contributions of these agents could not be assessed.6 
While this study only evaluated the effects of direct exposure to the solutions, the authors 
discuss the implications of the interaction between the solutions and lens materials. While 
disinfecting agents are not able to penetrate lens surfaces, evidence has demonstrated the ability 
of silicone hydrogel lenses to adsorb components, such as Polyquad® and PHMB, and 
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subsequently release these agents onto the corneal surface post-insertion.6 Evidence has also 
shown that certain lens-solution combinations can lead to different effects on the cornea. The 
authors discuss the importance of rinsing lenses, prior to insertion, to remove surface deposits of 
adsorbed disinfecting agents, but this also suggests that moving forward in this field, lenses 
should be included as part of the model for evaluating cytotoxicity.6   
3.  TISSUE CULTURE 
a. ANIMAL CELL CULTURE MODELS 
One of the earliest tissue cell culture models developed for ocular irritancy screening was 
developed using a non ocular cell source.  The Madin Darby Canine Kidney (MDCK) cell line is 
an epithelial cell line, with tight junction characteristics similar to the outermost layer of the 
cornea.22 Since chemical irritants can weaken the tight junctions and permeabilize the corneal 
epithelium, allowing the toxic agent access to underlying tissue, this property is important in 
assessing the cytotoxic potential of solutions.23 Several assays, neutral red release (NRR) and 
fluorescein leakage, have been designed to take advantage of this property and evaluate the cell-
cell attachments.23 The NRR assay evaluates cells that have been preloaded with neutral red dye. 
The assay can then assess the potency of a test chemical based on the ability of the solution to 
cause the preloaded cells to release the neutral red dye.23 
Following treatment with test solution, amount of fluorescein diffusing across the epithelium 
can be evaluated using a plate reader. This assay was used to evaluate the effect on the integrity 
of the corneal epithelium following treatment with undiluted ReNu MPS, ReNu MultiPlus, Opti-
Free, Opti-Free Express (with Aldox), Solo Care and Complete Comfort Plus for 20 minutes.  
32 
 
Opti-Free Express exhibited the greatest permeability, as indicated by the greatest fluorescence, 
which was significantly different from controls and all other solutions (Figure 3.3). Opti-Free 
was also significantly different from controls and all other solutions. 
 
Figure 3.3: The effect of contact lens multipurpose solutions on MDCK epithelial permeability.24 
Reprinted from Contact Lens Association of Ophthalmologists. Tchao R, McCanna DJ, Miller MJ. 
Comparison of contact lens multipurpose solutions by in vitro sodium fluorescein permeability assay. 
CLAO J. 2002; 28: 151-156, with permission from Wolters Kluwer Health.  
 
Scanning electron microscopy (SEM) revealed that cells exposed to Opti-Free Express 
showed a loss of tight junctions and microvilli, and damaged cell membranes, including 
membrane blebbing and folding. Similar loss of tight junctions and cell membrane damage was 
observed in Opti-Free.  All other solutions showed tight junctions and intact cell membranes, 
similar to that of controls. The SEM confirmation of compromised tight junctions and damaged 
membranes, allowed for correlation of the increased fluorescein permeability, by both Opti-Free 
solutions, to physiological damage to the MDCK cultures (Figure 3.4).23 The authors postulate a 
new possible agent responsible for the toxicity and cell damage resulting in permeability. Both 
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Opti-Free solutions contain citrate buffer. It is possible that the presence of citrate buffer may 
cause a depletion of extracellular calcium, leading to the breakdown of tight junctions due to the 
disruption of the normal localization and incorporation of ZO-1, an essential tight junction 
protein, to the plasma membrane.23 
 
Figure 3.4: Scanning electron micrograph (SEM) view of MDCK cell monolayer culture exposed to OFX, 
Hanks’ balanced salt solution (HBSS) (magnification × 1000). 24 
Reprinted from Contact Lens Association of Ophthalmologists. Tchao R, McCanna DJ, Miller MJ. 
Comparison of contact lens multipurpose solutions by in vitro sodium fluorescein permeability assay. 
CLAO J. 2002; 28: 151-156, with permission from Wolters Kluwer Health.  
 
Several in vitro studies have also compared the cytotoxicty of MPS to that of contact lenses. 
It is important to not only consider the cytotoxicity of liquids (i.e. MPS), but also the toxicity of 
solids (i.e. contact lenses).25 It is also essential to consider that the interaction between the solids 
and the liquids must be tested for cytotoxicity as well (i.e. contact lens – MPS combinations). 
Vaughan et al developed a cytotoxicity assay for use with contact lenses, where cells are placed 
in direct contact with the contact lens and the contact lens solution.25 With minor modifications, 
this assay can also provide kinetic data to assess mechanism and rate of toxicity. A mouse 
fibroblast cell line was used; harvested cells were divided into two equal volumes, to allow for 
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the parallel testing of solutions and lens-solution combinations.25 One portion of cells was further 
subdivided into enough tubes to resuspend cells in all test solutions. For the lens test run in 
parallel, the 2nd volume of the cell suspension were placed into the cup formed by a contact lens, 
and placed in a well of a culture plate. The polymacon contact lenses were soaked for 4 hours in 
the test solution, and blotted dry prior to use. The cells were incubated in the tubes and lenses for 
15 – 240 minutes. A portion of the cells were removed and mixed with acridine orange and 
propidium iodide, to assess effect on viability.  
The MPS containing 0.005% chlorhexidine, and 0.0005% chlorhexidine plus 0.001% 
thimerosal were all significantly toxic as solutions, but lenses soaked in these solutions were 
relatively safe. This indicates that lenses soaked in these solutions should be rinsed prior to lens 
insertion, to prevent any residual solution adsorbed on the lens surface from contacting the 
ocular surface.25 Both Polyquad® 0.001% and PHMB 0.00005% did not show a cytotoxic effect 
in either of the assays. While Polyquad® was found to be relatively safe in this study,25 many 
other studies disagree.4,24,26,28,30 The discrepancy could be due to the difference in incubation 
times with test solutions. This study had shorter time points, and the assay may not be sensitive 
enough to detect differences at these earlier time points. What is more interesting is the result 
that the combination of a lens with the Polyquad® solution is also non-toxic, which is consistent 
with whole animal in vivo studies. One must consider that clinically, MPS only comes into 
contact with the corneal surface by deposits, which were adsorbed onto the contact lens during 
the overnight disinfecting cycle. It is important for in vitro models to model the clinical condition 
as close as possible to accurate predict toxicity, such as evaluating the effect of MPS release 
from a contact lens. This method is useful in that it can detect both the cytotoxic potential of 
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solutions alone, and solution-lens combinations, and thus aids in establishing the toxicity profile 
of a solution-lens combination.  
While Polyquad® solutions were considered non-cytotoxic in the previous study,25 another 
study using solution-lens combinations and direct contact in a mouse fibroblast cell culture 
model had a different result.26 The study evaluated the cytotoxicity potential of AOSept, Solo-
Care, Opti-Free Express (with Aldox®), ReNu Multi-purpose solution, ReNu MultiPlus and 
Complete, using the USP direct contact test and three modifications to the USP elution test: 
trypan blue uptake method, cell regrowth method and quantification of viable cells. While the 
previous study looked at lens contact with a cell suspension,25 this study examined the effect of 
lens contact with a confluent monolayer.26 Cells were scored for biological reactivity (cellular 
degeneration, cellular malformation, and trypan blue uptake by non-viable cells) and size of the 
zone of reactivity, where grades of 2 or less met the test requirements and were not considered 
cytotoxic, whereas grades 3 and 4 were considered cytotoxic.26 Opti-Free Express was the only 
solution having a grade of 2 or higher on all tests, and was therefore, in contrast to the previous 
study, deemed cytotoxic. However, while both ReNu solutions did not score higher than 2 on any 
of the grading scales, which is in accordance to results from the previous study,25 viability as 
determined by the cell count was similar to that of Opti-Free Express, at less than 50% of the 
saline control. This result indicated that while exposure does not damage cell membranes, the 
exposure did inhibit cell growth.26 
Similar to using cell regrowth as a method of assessing cytotoxicity, colony-forming rate can 
also be used as a measure of a solutions potential toxicity.5 Chinese hamster lung fibroblast V79 
cell line is another accepted cell line used for testing of ocular toxicity.5 Cultured fibroblasts 
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were exposed to diluted MPS at concentrations ranging from 1.25% to 10%. After 6 days of 
culture, cells were fixed with ethanol and stained with 2% Giemsa solution. Numbers of 
colonies, containing 50 or more cells, were counted and the colony forming rate was calculated 
for each test solution as a fraction of the negative control group. Of the solutions tested, only 
Complete and Menicare Soft did not significantly affect colony forming rate at any 
concentration, and were therefore considered non-cytotoxic. Solo and Opti-Free Express showed 
little to no cytotoxicity at 1.25%, but showed a dose-dependent increase in cytotoxicity. ReNu 
MultiPlus was highly cytotoxic at concentrations of 2.5% and higher, while ReNu MoistureLoc 
was cytotoxic at all concentrations tested. From their results, a scale of cyotoxicity was derived 
where Complete ≤ Menicare < Solo ≤ OFX < ReNu MultiPlus < ReNu MoistureLoc.5 The study 
also looked at the effect that surfactants, buffering and isotonic agents had on the colony-forming 
rate, in an attempt to explain the scale of cytotoxicty. Of the surfactants tested, poloxamer 407 
and Tetronic 1107 were found to be cytotoxic. These surfactants are components of Solo and 
ReNu MultiPlus, respectively, and may have contributed to their cytotoxicity. ReNu 
MoistureLoc contains both of these surfactants, which may account for the increased cytotoxicity 
compared to all other solutions and ReNu MultiPlus.5 Of the buffering and isotonic agents, boric 
acid and 2-amino-2-methyl-1-propanol (AMP) were cytotoxic at concentrations of 0.1%. The 
presence of these agents in the ReNu solutions (boric acid only) and Opti-Free Express (both 
agents), may help to explain their cytotoxicity.5 Previously, the presence of citrate buffer was 
hypothesized as the cytotoxic agent of Opti-Free Express, as it could disrupt tight junction 
proteins.24 While citrate is still present, the addition of borate replaces citrate as the primary 
buffering agent. Other studies have also attributed the preservative Polyquad® as being the 
cytotoxic agent.3,4,6,9,21,26-28 Neither of these components were included in this study,5 so at the 
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present time, we are unable to compare the cytotoxicity potential of citrate or Polyquad®, nor 
conclude that any particular one is responsible for the cytotoxicity of OFX.  
There has also been extensive debate regarding PHMB, which is the preservative in 
ReNu.While some assays find it to be cytotoxic2,4,5,8, others do not.24, 27-29 Both ReNu and 
Complete contain the same preservative, but very often have markedly different effects on cells. 
While it has been postulated that the different chemical composition of the two solutions may 
account for the difference, no study has addressed this issue. The Santodomingo study is the first 
study5 that not only postulated that other constituents, such as buffering agents and surfactants, 
may be the cause of ReNu-induced cytotoxicity, but also evaluated the individual components. 
Like Polyquad®, PHMB was not evaluated in this study5 and cannot be compared to boric acid, 
Tetronic 1107 and poloxamer 407. 
Another indicator of cell growth (cell differentiation and tissue homeostasis) is gap 
junctional intercellular communication (GJIC).29 This assay was first used in an earlier study31 
using V79 cells, which reported that the concentration which suppresses cell growth to 50% of 
control assays (IC50) was found to be the lowest for ReNu at 1.8 vol%, whereas both Complete 
and Opti-Free had values greater than 10%, indicating no inhibitory action on GJIC. This 
indicated that much lower concentrations of ReNu have greater cytotoxic effects on cultured V79 
cells, compared to the other solutions tested, which are only cytotoxic at higher concentrations. 
Since the main disinfecting and surfactant agents (Table 3.2) of ReNu are PHMB and Tetronic 
1107, these constituents were evaluated individually. It was found that Tetronic 1107 had the 
lowest IC50, at 0.25%; this data suggests that Tetronic 1107 is the component of ReNu 
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responsible for inhibition of GJIC. Poloxamer 407, another type of surfactant (Table 3.2), also 
had the same observed inhibitory effect as Tetronic 1107.31  
Following this study, Sumide et al,30 used a rabbit keratocyte cell culture model to assess the 
effects of MPS on GJIC using a Scrape Loading and Dye Transfer (SLDT) test. Confluent 
keratocytes were treated in a 35mm2 dish, with diluted test solutions. After the incubation period 
with MPS, 10 scrapes were made in the cell monolayer with a steel blade scalpel, and 0.2% 
Lucifer yellow dye was added. The distance that the Lucifer yellow travelled was measured; if 
there was an adverse effect on the cells, the distance of the dye transfer would decrease due to 
inhibition of GJIC by the MPS (Figure 3.6).30 The study evaluated the effect of both 
concentration and time. In the rabbit keratocyte cell culture model, ReNu again showed the 
greatest disruption of GJIC at concentrations from 0.3125% to 10%.30 Inhibition only occurred at 
much higher concentrations of Complete and Opti-Free, at 2.5% and 10% respectively. The 
relevance of inhibition induced by these concentrations was not discussed.  Western blot analysis 
revealed that in normal, untreated cells, 3 bands were present for connexin-43, which is a major 
gap junctional protein found in rabbit keratocytes. The results corresponded to the degree of 
phosphorylation.  After 30 minute exposure to ReNu at 0.625%, the total level of connexin-43 
was reduced, and further analysis revealed that there was a decrease in P2, the highly 
phosphorylated form. After a 24 hour recovery period, total levels, including P2, had recovered. 
The inhibitory action on GJIC may be related to the change from phosphorylated connexin to the 
dephosphorylated form, as phosphorylated connexin is important for accurate assembly and 
distribution of gap junctions.30  
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Further evaluation with PHMB, Tetronic 1107 and poloxamer 407 showed that Tetronic 
1107 had the greatest inhibition at concentrations from 0.0313% to 10%, while inhibition was 
seen with 1% PHMB. This assay was sensitive enough to detect differences between Tetronic 
1107 and poloxamer 407. Poloxamer 407 was similar to PHMB in that inhibiton of dye 
migration was only significant at a concentration of 1%.30 While the authors conclude that the 
differences observed in poloxamer 407 is due to the increased sensitivity of the SLDT assay, it is 
difficult to conclude whether it is due to the assay or the cell line. The results from the V79 
Sumide study30 are in agreement with the work of Santodomingo et al5 whose findings with the 
same cell line hypothesized that poloxamer 407 was the cytotoxic agent in SoloCare MPS. These 
results indicate the importance of cell source and type on the relevance of cytotoxicity testing.    
Primary bovine corneal epithelial cultures are also commonly employed to characterize 
toxicity profiles of MPS. Pham and Huff9 tested four solutions, ContaClair, Opti-Free 
Disinfecting, Rinsing and Storage Solution, ReNu Sensitive Eyes MPS and Lens Plus Saline, in a 
bovine model. Three assays were used to assess cytotoxicity following exposure to increasing 
concentrations of test solutions for 4 days. Lactate production assay was used to assess cell 
glycolytic activity or anaerobic profile.9 An increase in absorbance was directly proportional to 
concentration of lactate.9 AlamarBlue is a cell viability assay, previously described as an assay 
used to quantify cells based on reduction potential. Kenacid blue assay evaluates the total protein 
biomass. The binding of kenacid blue dye is directly related to protein content, and as such can 
also quantify cell number.9 This battery of tests were all performed on the same well, and was 
very useful in being able to provide a wealth of information from a single well. The data was 
reported as log concentration curves, and the authors looked at the IC50, to compare the relative 
potency of test solutions. For all solutions, Alamar blue and kenacid blue were consistent in their 
40 
 
assessment of IC50. The lactate production assay was consistently higher, but only significantly 
higher in Opti-Free. All 3 MPS showed similar log concentration curves, in sharp contrast to the 
Lens Plus saline solution, which was not toxic to cell metabolism or proliferation at any of the 
concentrations investigated. For lactate production and cell respiration, Opti-Free had a 
significantly higher IC50, indicating that a higher concentration was needed to elicit the same 
toxic response observed in lower concentrations of Contaclair and ReNu (Figure 3.5).9 The 
cytotoxicity ranking determined from this battery of tests was Lens Plus Saline << Opti-Free ≤ 
Contaclair ≤ ReNu.9  
 
Figure 3.5: Log concentration response curves for contact lens solutions determined by the lactate 
production assay. 9 
Reprinted from Contact Lens Association of Ophthalmologists. Pham XT, Huff JW. Cytotoxicity 
evaluation of multipurpose contact lens solution using an in vitro test battery. CLAO J. 1999; 25: 28 – 35, 
with permission from Wolters Kluwer Health. 
 
The cytotoxicity of ReNu and Contaclair may be contributed to by the presence of both 
disodium edetate (EDTA) and boric/borate buffer.9 The toxic potential of borate has been 
demonstrated before,5,31 but EDTA is a component of MPS that has not been investigated as 
thoroughly. EDTA can chelate Ca2+ and Mg2+ and may compromise normal cellular functions, by 
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inducing cell rounding, leading to detachment.9  While EDTA is common among most MPS, 
ReNu has the highest concentration of EDTA compared to any given solution currently on the 
market.9 At 0.1%, the concentration of EDTA in ReNu is 2 times that in OFX, 4 times that in 
Solo, and 10 times that of Complete.9 EDTA needs to be more thoroughly researched, as it is one 
component of ReNu and other PHMB based solutions which is highly variable. PHMB was also 
presumed a cause of the metabolic and structural damaged that inhibited cell proliferation.9 The 
results with Opti-Free were consistent with in vivo observations by Begley et al,2 but in 
disagreement with other tissue culture models discussed previously.4,24,26,28,30  The explanation 
may be due to a change in formulation. The Opti-Free solution used in this study9 and the Begley 
study2 contains citrate buffer and PolyQuad. More recent studies use a new formulation of Opti-
Free that contain borate buffer as the primary buffering agent, which has largely been speculated 
as a cytotoxic agent, as well as Aldox and other new surfactants (such as TearGlyde). Solutions 
themselves should not solely be deemed cytotoxic, but rather the specific formulation or 
constituents. The change from a citrate only solution to a solution with both citrate and borate 
buffer may be responsible for the changing trend of Opti-Free cytotoxicity observed in other 
studies.  
A study by Cavet et al, also used an in vitro bovine corneal epithelial model, with the newly 
formulated Opti-Free Express and RepleniSH.29 The primary focus of this study was in an 
immortalized human cell line, which is discussed in the next section, but the primary bovine 
cultures demonstrated results in stark contrast to the previous study, but consistent with the 
observations of the newly formulated Opti-Free solutions as made by several studies.15,17,33 A 
significant reduction in ATP content of 40% or more was observed with both Opti-Free Express 
and RepleniSH. An LDH release assay assessing membrane integrity also detected a significant 
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increase in release from cells exposed to both Opti-Free solutions.29 The data suggested that the 
evolution in the formulation of Opti-Free solutions has contributed to its increasing cytotoxicity 
potential. Table 3.1 (page 25) highlights the changes in formulation and the solutions, which 
have replaced older generation MPS. 
b. Immortalized human cell culture models 
Animal cell line and primary cell cultures are valuable for assessing morphological changes, 
cell degeneration, cell death and other parameters of ocular irritation and inflammation, but there 
can be considerable variation in donor material and primary cultures, low reproducibility and a 
short lifespan.33-35With most animal cell lines, there is often little relevance to humans due to 
differences in ocular anatomy, physiology and biochemistry. In primary cultures or isolated 
tissue models, cells can become senescent after several passages, therefore, having a restricted 
lifespan.33-35 The availability of donor material for such models is uncertain.33An immortalized 
human cell line, that retains features of the original tissue, would be an ideal system to model the 
human ocular surface in vitro and study mechanisms underlying ocular toxicity.1 There are many 
advantages to an immortalized human system: continual passability, storage and revitalization, 
ease of handling, reproducibility, among others.33-35 These cell lines can be acquired by 
transfection or infection of primary cultures with oncogenic DNA viruses or essential fragments 
of host DNA.33-35 
Between 1993 and 1999, Kahn, Araki-Sasaki and Offord,33-35 all developed immortalized 
human corneal epithelial cell lines, with the intention of modelling the ocular surface for toxicity 
and irritation studies. These lines have been used extensively in ocular toxicity work, specifically 
evaluating MPS. The cell lines have been characterized based on differentiation and 
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metabolism.33-35 In knowing that the cell lines can stably express a broad spectrum of metabolic 
enzymes, cytokines and growth factors, a battery of tests can be performed to not only assess 
toxicity and inflammation, but also investigate mechanisms.  
Araki-Sasaki cells were used in a study to evaluate the effect of MPS on cell viability, 
apoptosis rates, and integrity of tight junctions.3 Test solutions included Complete EasyRub, 
Opti-Free Express, Opti-Free RepleniSH and ReNu MultiPlus diluted with culture medium. To 
assess cell viability, an MTT assay was used. The MTT assay is a colorimetric assay based on 
the tetrazolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide).36 It 
can be bioreduced in metabolically active cells into a purple formazan product.36 Only functional 
mitochondria can convert MTT into this product, and the changes in absorbance related to the 
formation of formazan can be detected using a micro plate reader.36 Apoptosis rates were 
evaluated using a Tunel (terminal deoxynucleotidyl transferase-mediated dUTP nick end 
labelling) DNA fragmentation assay. This assay used an antidigoxigen antibody conjugated to a 
fluorescein reporter molecule to identify changes in DNA fragmentation. Cells were exposed to 
test solution for 30 minutes and Tunel assay was performed using ApopTag fluorescein in situ 
apoptosis detection kit. The cells were fixed and incubated with TdT enzyme. Positive and 
negative cells were counted manually at 100x magnification. Fluorescein permeability and tight 
junction protein staining were used to evaluate the effect of MPS on tight junctions. Like the 
MDCK assay23, cells were grown in filters and the amount of fluorescein that permeated the cell 
monolayer following treatment was quantified fluorometrically. Tight junction protein staining 
was performed following 2 and 6 hour incubation with the test solution (Figure 3.6). The MTT 
assay revealed significant differences in viability after 6 hour exposure to Opti-Free Express, 
Opti-Free RepleniSH and ReNu. OFX and ReNu showed a time dependent decrease in viability. 
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Tunel assay revealed that OFX, OFR and ReNu also had a significant increase in apoptotic cells, 
at 16.5%, 12.6% and 10.2% respectively. ReNu and OFX had the greatest amount of 
permeability, with OFR showing a lesser degree of permeability. In the histochemical analysis, 
all 3 solutions also showed significant disruption of ZO-1 and occludin tight junction proteins. 
 
Figure 3.6: Representative images of immunofluorescent staining for ZO-1 (green) in human corneal 
epithelial cells after 2 and 6 hrs exposure to each of the 4 MPS studied. Strong green staining between the 
cells indicates intact ZO-1 tight junction proteins while the weak or negative staining shows disrupted 
junctions. Hoechst 33342 (blue) was used for cell nuclear counterstaining.3 
Reprinted from Eye & Contact Lens. Chuang EY, Li DQ, Bian F et al. Effects of contact lens 
multipurpose solutions on human corneal epithelial survival and barrier function. Eye Contact Lens. 2008; 
34: 281-286, with permission from Wolters Kluwer Health. 
 
Cell membrane integrity can also be evaluated using a NRR assay, as previously described 
in its use in MDCK cells.24 This assay was consistent with a previous study,27 in finding that 24 
and 48 hour exposure of transformed HCEC to ReNu and Opti-Free Express significantly 
affected cell membrane integrity, at concentrations of 5 and 10ppm. Solo and Complete did not 
have a significant adverse effect at any time point or concentration.27  
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Using SV-40 immortalized HCEC to evaluate tight junctions yielded a different response. 
Opti-Free Express again showed the greatest amount of permeability, a loss of tight junctions, 
decreased metabolic activity (Figure 3.7), and the appearance of damaged cell membranes, 
including membrane blebbing and folding.28 In this study, ReNu did not have adverse effects on 
the HCEC monolayer. The results from the McCanna study28 are consistent with the MDCK 
study,24 and more relevant given the use of human cells, but the finding that ReNu did not have 
an adverse effect is in disagreement with previous studies.3,5,9,26  
 
Figure 3.7: The results of alamarBlue assay after treating the cultures with various solutions. The results 
represent three separate experiments and are expressed as a percentage of the Hank's balanced salt 
solution activity. A reduced percentage, as seen with the Opti-Free Express–treated cultures, represents a 
toxic effect on cells.28 
Reprinted from Eye & Contact Lens. McCanna DJ, Harrington KL, Driot JY, et al. Use of a human 
corneal epithelial cell line for screening the safety of contact lens care solutions in vitro.  Eye Contact 
Lens 2008; 34: 6-12, with permission from Wolters Kluwer Health.  
 
The difference may potentially be accounted for by the difference in exposure time. For the 
previous studies, by Chuang et al3 and Wright et al,27 cells were exposed to test solutions for 6 
hours, and 24 – 48 hours, respectively. In contrast, the McCanna study28 treated cells with the 
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test solutions for only 15 minutes. The short time period may not have been long enough for the 
solution to have an effect. Additionally, the assays may not have been sensitive enough to detect 
smaller differences at such short time periods. In the Wright study, they note that their assays 
were more sensitive at the longer time point of 48 hours.27 It can be argued that shorter treatment 
periods are justified by the fact that blinking and the constant regeneration of the tear film may 
dilute the effects of the biocides in vivo. However, it should be considered that the uptake and 
slow release by the contact lens will increase the exposure time to the cornea, which further 
warrants the importance of evaluating longer exposure to test solutions and solution release from 
a contact lens in vitro, possibly at lower concentrations than that typically evaluated. 
Characterization of the lens release profile would provide information about rate of release and 
concentration of released biocides, which would then provide experimenters with the ideal 
concentration to evaluate.    
Another recent study using immortalized human cell lines also looked at the effect of MPS 
on brief time courses.29 Cells were exposed directly to 100% ReNu MultiPlus, Opti-Free 
Express, Aquify and Opti-Free RepleniSH over a 2 hour time course, or to increasing 
concentrations, diluted in medium, between 20-100% for 2 hours. ATP quantitation and 
resazurin reduction were employed as measures of cell viability, using luminescence and 
fluorescence to estimate cell number. Both assays indicated that exposure to Opti-Free Express 
and Opti-Free RepleniSH reduced viability, in comparison to medium control for all 
concentrations, and to all test solutions for concentrations greater than 40%. ATP content was 
only significantly reduced by ReNu and Aquify at 100% concentration, but effects were still 
minimal compared to Opti-Free products. In examining that effect over time, Opti-Free Express 
and RepleniSH had a significant decrease in viability at 15 minutes. ReNu and Aquify did not 
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differ from medium controls at any timepoint.  This study also used primary bovine cultures to 
confirm that the results obtained from the immortalized cell line were not limited to transformed 
cells.29  The Opti-Free products showed a greater adverse effect compared to ReNu, which the 
authors concluded is supported by the literature, but there is a large body of industry and non-
industry sponsored studies that demonstrates the cytotoxicity of ReNu is comparable and in some 
cases greater than that of Opti-Free.3,5, 9,15,30 Like the McCanna study,28 the cells were exposed to 
the test solutions for a very short time, and may not be accurately predicting the full cytotoxic 
potential.29   
A study by Imayasu et al15 also looked at the effect of MPS on structure and barrier function 
of epithelial tight junctions, while specifically comparing borate buffer based MPS; ReNu 
MultiPlus, ReNu MoistureLoc and Opti-Free Express, to unbuffered Menicare Soft.15 Integrity of 
tight junctions was assessed by immunohistochemistry, transmission electron microscopy (TEM) 
and transepithelial electrical resistance (TER). Cells were exposed directly to test solutions for 
60 minutes, prior to incubation with ZO-1 antibody. For TEM, cells were only exposed to test 
solutions for 15 minutes before being fixed. Similar to NaF permeability studies, cells were 
grown in filters in wells to measure the TER. The test solution was added to each filter, while the 
well remained full of serum free medium. TER readings were measured, at time 0, 30, 60 and 
120 minutes.  Confocal analysis of tight junctions found that all three buffered solutions showed 
partially destructed ZO-1 structure, with discontinuous, wide spreading intercellular spaces. 
Menicare showed a normal, continuous distribution of ZO-1 along cell-cell borders. By TEM, it 
was also observed widely opened junctions after exposure to ReNu MultiPlus and Opti-Free 
Express; whereas ReNu MoistureLoc had both partially opened and tightly closed tight 
junctions. The quantitative results from the TER assay also confirmed these findings. Menicare 
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and ReNu MoistureLoc showed no difference in electrical resistance over time. ReNu MultiPlus 
and Opti-Free Express showed a significant reduction in resistance, and on collagen membranes, 
lost all electrical resistance after 120 minutes. The results suggest that ReNu MultiPlus and Opti-
Free Express, and to a lesser extent ReNu MositureLoc, have the potential to cause destruction of 
barrier function.  The authors hypothesize that the adverse effect is likely mediated through the 
MAPK pathway.15 Activation of this pathway could lead to destruction of tight junction structure 
and epithelial barrier function,15 but this pathway needs to be specifically studied before making 
any definitive conclusions. 
The adverse effect of ReNu MultiPlus, Opti-Free Express and ReNu MoistureLoc may be 
due to the concurrent use of boric acid as a buffer and the poloxamine family of surfactants.15 
The authors hypothesized that these components may be responsible for the adverse effect on 
tight junctions. Their hypothesis was further supported by work by Santodomingo et al,5 who 
demonstrated the cytotoxic potential of various buffers, surfactants and isotonic agents found in 
MPS, as discussed previously. The authors tested their hypothesis using 1% diluted poloxamine 
and boric acid (Figure 3.8). While poloxamine showed almost no effects on tight junctions 
(Figure 3.8A), the boric acid showed the same discontinuous partially destructed ZO-1 structure, 
which was observed with the three buffered solutions (Figure 3.8B). While the evidence from 
ReNu MultiPlus and Opti-Free Express strongly suggests that boric acid may be responsible for 
the adverse effects on tight junctions, more quantitative work is necessary.  In addition, viability 
assays need to be included in this series of cytotoxicity testing, to be able to correlate whether 




Figure 3.8: Confocal laser scanning micrographs of ingredient-treated human corneal epithelial cells 
stained with ZO-1 antibody and counterstaining with propidium iodide (original magnification, 400×). 
(A) Treatment with 1% poloxamine for 60 minutes. (B) Treatment with 1% boric acid for 60 minutes.15 
Reprinted from Eye & Contact Lens. Imayasu M, Shiraishi A, Ohashi Y, et al. Effect of Multipurpose 
Solutions on Corneal Epithelial Tight Junctions. Eye Contact Lens. 2008; 34: 50-55, with permission 
from Wolters Kluwer Health.  
 
Recently, the use of stratified cultures has been used to more closely model the multilayered 
cornea.37 The study evaluated the validity of in vitro toxicity testing measures, by comparing 
monolayer and stratified HCEC cultures.37 The authors hypothesized that monolayer and 
stratified culture models will yield different results, using traditional cytotoxicity assays. While 
the results suggested that monolayer cultures appeared to be more sensitive to MPS exposure, 
there was only a direct comparison of the two models on the basis of morphology and viability 
by fluorescence microscopy, which were both analyzed subjectively by imaging software. 
Without a direct comparison of monolayer and stratified cultures using objective assays, it is 
difficult to call into question the validity of monolayer in vitro modelling systems.  
Contact lens wear and use of contact lens solutions can also cause reactions on the 
conjunctival surface.38 Several recent studies have been undertaken to examine whether MPS can 
also damage human conjunctival cells. The earliest of these studies looked at the effects of Opti-
Free, ReNu, SoloCare and Titmus.38 The primary conjunctival fibroblast cultures were treated 
for 24 hours with varying concentrations of test solutions. The effect of the solution was 
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evaluated using the MTT assay and a cell analysis was performed using the CASY-1 system to 
obtain an absolute cell count.  At 1%, Opti-Free and Titmus demonstrated a siginificant 
reduction of mitochondrial activity, as detected by the MTT assay. At 5%, all solutions exhibited 
a significant effect. No significant effect was detected at concentrations lower than 1%. Similar 
trends were seen with the absolute cell count, where cell number decreased with increasing 
concentration, although this data was not significant. 
A similar study was conducted using an immortalized human conjunctival cell (HCC) line. 
They also evaluated cell viability, but in this study membrane integrity (neutral red test) and 
intracellular redox status (alamar blue test) were used as measures of conjunctival viability. In 
addition, the study evaluated oxidative stress, by production of reactive oxygen species (ROS) 
and superoxide anions. A focus was also placed on changes to the mitochondrial mass and 
membrane potential, and activation of the cell death receptor P2X7. Mitochondrial mass was 
assessed using the NonylAcridine Orange test, which uses a dye to stain lipids found specifically 
in the mitochondrial inner membrane. Mitochondrial potential was measured using the JC-1 test. 
Red fluorescent J aggregates are detected when mitochondrial activity is high; green fluorescent 
J monomers are detected when mitochondrial activity is low.14 Activation of P2X7 cell death 
receptor was detected using YO-PRO-1, which was previously used in an isolated tissue model 
to visualize the nuclei and identify apoptotic-related alterations in the nuclear membrane by 
confocal microscopy.21 This fluorescent DNA probe can enter the apoptotic cells via activated 
P2X7 pores, and can quantify apoptotic cells in a population by flow cytotmetry. 39 P2X7 
receptors are non-selective cation channels, known to induce apoptosis.14 They facilitate the 
influx of extracellular calcium, which can contribute to the generation of ROS.14  The results 
found that at 15 minutes only OFX induced a significant loss of membrane integrity and decrease 
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of intracellular redox potential. It was also demonstrated that OFX could stimulate an 
overproduction of ROS and anion superoxides. At the 3 hour time point, OFX was even more 
cytotoxic in terms of these parameters. ReNu and Solo also induced a significant decrease in cell 
viability and redox potential, at 3 hours only. At 3 hours, Solo induced an overproduction in 
ROS, while Complete and ReNu induced a decrease. For both time points, mitochondrial mass 
was found to increase with OFX exposure, and decrease with ReNu and Solo exposure. 
Increased mitochondrial size, forming megamitochondria, is an indicator of oxidative stress. 
OFX caused a decrease in mitochondrial potential, and induced activation of the P2X7 receptor, 
adding support to the hypothesis that oxidative stress can lead to apoptosis. The authors 
hypothesize that the concentration of the biocide is responsible for the differences in oxidative 
stress and apoptosis. The concentration of preservatives such as Polyquad® in OFX (0.001%) is 
10 times that of PHMB in ReNu, Solo and Complete (0.0001%).14 Solo also caused P2X7 
receptor activation, and further study into mechanism of Solo induced apoptosis was necessary. 
While Solo has the same preservative as ReNu and Complete, the difference in cytotoxicity may 
be due to the difference in buffers, EDTA concentration or PHMB polymer size as previously 
discussed.14  
Similarly, the same cell line was used to evaluate caspase 3 activity and chromatin 
condensation, induced by OFX and Solo.  Hoescht 33342 and propidium iodide (PI) were used to 
image chromatin condensation, a morphological change characteristic of apoptosis.40 Hoescht 
can enter living and apoptotic cells, whereas PI can enter necrotic cells.40 Both OFX and Solo 
significantly induced caspase 3 activity, with OFX inducing levels similar to the apoptosis 
inducer, camptothecin. Both OFX and Solo also caused a significant increase in chromatin 
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condensation, 8.8x and 2.6x, and activated P2X7 cell death receptors, 9.8x and 1.9x, 
respectively.  
The finding that Solo also induced caspase 3 activity is contrary to results from our own 
laboratory work with HCEC, where only OFX activated caspase 3. The difference may be 
accounted for by two reasons; cell type or concentration. While conjunctival cells may come into 
contact with residual solution on lenses post insertion, the main contact is with the corneal 
epithelium.3 The different cell types may have different physiological responses to toxic 
solutions, and/or conjunctival cells may be more sensitive to solutions compared to epithelial 
cells. If such is the case, conjunctival cells are an inappropriate cell line to model the 
mechanisms of toxicity in epithelial cells. This is not to say that the effect on conjunctival cells is 
to be dismissed, only that drawing conclusions about epithelial cells from conjunctival models 
may not be entirely accurate. Another key difference between the studies is the concentration of 
test solution exposed to the cell cultures. The Dutot study used the undiluted solution directly, 
whereas the study from our laboratory looked at the impact of solution released from silicone 
hydrogel contact lenses. The concentration of solution released from contact lenses is very likely 
to be much less than 100%, so the use of undiluted solution directly overestimates the 
concentration the ocular surface would normally be exposed to and may account for the 
increased activity caspase 3 induced by Solo. 
4. Conclusions (Tiered Testing Strategies) 
The literature reviewed demonstrates a wealth of knowledge in the field of ocular toxicity 
testing, using whole animal, isolated tissue and tissue culture models. Table 3.3 summarizes the 
models and assays used to assess ocular toxicity and biocompatibility of MPS. While there are 
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still many differences between the findings from in vivo and in vitro testing strategies, in vitro 
testing, using tissue culture, is becoming increasingly accepted as a valid tool for toxicology and 
biocompatibility studies.34,41-43 As discussed, many laboratories currently employ this model to 
screen for the potential cytotoxicity of multipurpose solutions.  
Currently, there is no single in vitro test that has been accepted as an alternative to the Draize 
test and the prospect of eliminating whole animal testing is a challenge.1 A stepwise system 
employing all three models may help to address the criticisms and concerns surrounding the 
Draize test. The first step would involve a detailed literature review of the physiochemical and 
biotoxicological data of the proposed compounds, and related substances.1 Skin irritancy would 
be assessed in the next step for compounds found by the literature review to not be toxic.1 
Following dermal irritation testing, an in vitro test battery can be performed with compounds 
found to be non-corrosive to the skin, using whole tissue or tissue culture models.1 Specifically, 
cultured corneal epithelial cells are advantageous for irritancy screening.34,41-43 CEC are 
potentially more predictive of ocular irritancy responses compared to other cell lines.9 These 
cultures can be used to study mechanisms of cytotoxicity, which cannot be investigated easily in 
vivo, or clinically.9 In vitro models are reproducible, sensitive, relatively fast, easy to execute, 
cost effective, and have standardized endpoints for easy comparisons.1,9, 27,29 Compounds, which 
display non-serious irritancy can then be tested on one animal, using the Draize test, before 
repeating with a large scale in vivo study.1 Use of the stepwise system reduces sample size in 
whole animal studies based on information acquired in the previous tier or step; in vitro cell 
culture and isolated tissue systems can also provide mechanistic data on toxic effects.1 In using 
all three systems collectively, we can acquire a wealth of knowledge about the safety and 
efficacy of new ocular drugs or MPS. 
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Table 3.3: Measures for assessing ocular toxicity and biocompatibility of MPS (Adapted from 
Wilhemus, 2001) 
Measures for Assessing Ocular Toxicity and Biocompatibility of Multipurpose Solutions 



































































































































THE IMPACT OF MULTIPURPOSE SOLUTIONS RELEASED FROM SILICONE 
HYDROGEL LENSES ON CORNEAL EPITHELIAL CELL VIABILITY, ADHESION 
PHENOTYPE AND APOPTOTIC PATHWAYS IN VITRO 
INTRODUCTION 
Ocular toxicology and biocompatibility studies have been increasingly conducted using 
corneal epithelial cell culture models and many laboratories currently employ this model for 
screening of new compounds and assessing potential safety and ocular irritation issues.1-3 
Recently, cell culture models have been used to screen for the potential cytotoxicity of 
multipurpose solutions used to clean and disinfect contact lenses.4-7  
The disinfecting properties of multipurpose solutions (MPS) are conferred by the active 
biocide, which are commonly a polyquaternium, biguanide or hydrogen peroxide agent.8 MPS 
also contain a buffering solution, which is typically either borate or phosphate-based.8 The 
physical properties of the chemical polymers used in hydrogel and siloxane-based contact lens 
materials allow for the adsorption and absorption of components of these care regimens during 
the overnight disinfection cycle, followed by potential release onto the corneal surface during 
lens wear.  Certain combinations of MPS and silicone hydrogel lenses can lead to a cytotoxic 
effect in vitro4-6 and some combinations have the potential to exhibit excessive corneal staining 
in vivo.8-15 As a result of such observations, many biocompatibility studies have been undertaken 
to examine the effect of ophthalmic solutions, including contact lens packaging solutions and 
multipurpose solutions, on corneal and conjunctival cells.5-7, 16, 17 Many of these biocompatibility 
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studies have used extracts or dilutions of the care regimens to evaluate the potential corneal 
effect, or have used non-corneal cell types as a proxy. These studies were able to evaluate the 
potential cytotoxic effect of ophthalmic and multipurpose solutions in vitro, and while this is 
valuable research, there is currently limited information on the effect of the direct release of 
solutions from silicone hydrogel lenses on human corneal epithelial cells. Previous studies have 
shown that lens type will affect uptake and release of compounds contained in MPS,18 and this 
may also have an impact on any subsequent cytotoxic responses observed. Thus, to assess the 
cytotoxicity of agents contained in multipurpose solutions that would be released by contact 
lenses, a model in which the contact lens was directly set onto a monolayer of corneal cells was 
developed and corneal cell viability, adhesion phenotype and caspase activation were assessed 




MATERIALS AND METHODS   
Reagents and antibodies 
Keratinocyte serum free medium, growth supplement (Bovine Pituitary extract) and pen-
strep solution were purchased from ScienCell (Carlsbad, CA, USA).  All other cell culture 
reagents, Dulbecco’s minimum essential medium, fetal bovine serum, phosphate buffer saline 
and TriplExpress were purchased from Invitrogen (Burlington, Ontario, Canada).  Monoclonal 
antibodies to β1 integrin (CD29, Immunotech-Coulter, Marseilles, France) and β4 integrin 
(CD104, Serotec, Mississauga, Canada) were fluorescein isothiocyanate (FITC) conjugates.  The 
monoclonal antibody against α3 integrin (CD49c, Serotec, Mississauga, Ontario, Canada) was a 
R-phycoerythrin (PE) conjugate.  Parafomaldehyde was purchased from Fisher Scientific 
(Ottawa, Ontario, Canada) and all other chemicals used to prepare Hepes Tyrode Buffer were of 
analytical or reagent grade.   
Contact lenses and multipurpose solutions 
Two silicone hydrogel lens materials were tested: lotrafilcon A (LA from CIBA Vision, 
Duluth, GA, USA) and balafilcon A (BA from Bausch & Lomb, Rochester, NY, USA). All 
lenses were purchased in their original packaging, had a diameter between 14.0 and 14.2 mm and 
a curvature of 8.5 to 8.7mm. Four polyquaternium and biguanide preserved multipurpose 
solutions were tested and their composition is described in Table 4.1. 
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Buffer Other reported agents 
(surfactants and  chelating 
agents)19 




Borate Sorbitol; citrate (citric acid), 
0.05% EDTA; poloxamine 
(Tetronic 1304) 
AMO Complete Moisture Plus 
(Complete) 
PHMB 0.0001% Phosphate Taurine; 0.01% EDTA; 
Poloxamer 237 (Pluronic F87); 
HPMC 0.15%; propylene 
glycol 
Bausch & Lomb ReNu MultiPlus 
(ReNu) 
PHMB 0.0001% Borate Sodium borate; 
Hydroxyalkylphosphonate 
(Hydranata); 0.1% EDTA; 
Poloxamine (Tetronic 1107) 
CIBA Vision SoloCare Aqua 
(Solo) 
PHMB 0.0001% Tris Sorbitol; 0.025% EDTA; 
dexpanthenol (provitamin B5); 
Pluronic F127 (poloxamer 407) 
PHMB: polyhexamethylene biguanide (also known as polyhexanide, Dymed, polyhexadine, and 
polyaminopropyl biguanide)19 
 In vitro cell culture 
Immortalized human corneal epithelial cells (HCEC) 
 SV40-immortalized human corneal epithelial cells were cultured in keratinocyte serum 
free medium supplemented with bovine pituitary extract, recombinant epidermal growth factor 
and pen-strep (KSFM).  Fresh medium was added every other day and cells were grown to 90% 
confluency in tissue culture treated flasks.  Adherent cells were removed using a dissociation 
solution, TriplExpress (Invitrogen, Burlington, Ontario, Canada). Cells were routinely observed 
for any morphological changes.   
In vitro model 
A direct contact in vitro model was used.7  HCEC were seeded onto a 24 well tissue 
culture treated polystyrene (TCPS) plate at 105 cells per well.  Cells were left to adhere overnight 
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(18-24 hours) in a humid CO2 incubator, which resulted in the formation of a monolayer of 
HCEC. Simultaneously, 2 mL of MPS was added to the wells of a sterile 12-well polystyrene 
plate (BD Falcon, Mississauga, ON, Canada).  Using sterile tweezers, SH lenses were gently 
removed from their blister pack and added to the wells containing MPS.  SH were totally 
immersed and left to soak for 18 – 24 hours. All lens-solution soaking combinations were 
performed under sterile conditions. 
  The next day, supernatant was removed from the cells and fresh serum-free medium (700 
µL) was added. MPS-soaked SH lenses were placed gently on top of the monolayer, face-down, 
with the concave surface facing upwards and incubated for 8 and 24 hours at 37oC (5% CO2 in a 
humid incubator).  Lenses were totally immersed in medium.  After 8 and 24 hours, lenses were 
carefully removed from wells.  The lenses did not adhere to the HCEC monolayer.  Lenses were 
also routinely observed for the presence of adherent cells on their surface and no HCEC 
proliferation was observed.   
Cellular viability 
To measure cytotoxicity of the products released from the contact lenses, the MTT 
cellular viability assay was performed.  After a gentle rinse in sterile PBS, cells were incubated 
with a solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT at 
1mg/mL in KSFM medium).  After 3 hours at 37oC, cells were lysed with DMSO and 
absorbance read at 595nm (Thermo MultiSkan Spectrum Photometer, Fischer Scientific, Ottawa, 
ON, Canada).  All results are expressed as relative viability compared to cells grown in the 




Precycling of Lens Cases 
Cellular viability was also assessed to determine the difference between using precycled 
lens cases and tissue culture polystyrene wells. This methodology, which was developed by 
Alcon Laboratories, involved preconditioning the lens cases with their appropriate solutions for 
six 8-hour periods. The aim of preconditioning was to eliminate interactions between the solution 
and polymers of the lens case.9,10 Lenses were then soaked in the cases or sterile tissue culture 
polystyrene wells overnight before being placed on the monolayer. The MTT assay was repeated 
as described previously. 
Cellular activation 
To determine cellular activation by a change in integrin expression or caspase activation 
induced by MPS release from contact lens, HCEC were removed from the wells with 
TriplExpress (Invitrogen, Burlington, Ontario, Canada), following a gentle wash in PBS. Cells 
were washed and resuspended in DMEM/FBS.  
For integrin expression, small aliquots (30µL) of HCEC, diluted in DMEM-FBS, were 
incubated with saturating concentration of fluorescently-labeled antibodies for 1 hour at 4oC. 
Samples were then diluted in Hepes Tyrode Buffer, fixed in 1% paraformaldehyde (final 
concentration) and analysed by flow cytometry within 5 days.   
To determine caspase activation, small aliquots of HCEC, diluted in DMEM-FBS, were 
incubated with a fluorescently-labelled pan caspase inhibitor (FITC-VAD-FMK, Calbiochem, 
San Diego, California) for 1 hour at 37oC. Samples were washed and resuspended in wash 
buffer, before immediate analysis by flow cytometry.  
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All samples were acquired on Becton Dickinson FACSVantage flow cytometer 
(Mountain View, CA, USA) using CELLQuest Software. Appropriate isotype controls were used 
with each experiment. Analysis was also performed using FACSExpress post data acquisition.   
 Statistical analysis 
All results are reported as means ± standard deviation (SD). To evaluate the significance 
of the differences in cell viability and cell activation, an ANOVA was carried out followed by a 
post hoc Bonferroni test using Statistica V8 (StatSoft, Tulsa, OK, USA).  A p value of less than 
0.05 was required for statistical significance.  The number of experiments was equal to or greater 





Cell viability was assessed after incubation periods of 8 and 24 hours. For both time and 
lens types, there was no significant difference in cell viability between cells incubated in the 
absence of a lens and cells incubated with a PBS-soaked lens (p = 1.000).  At 8 hours, the borate 
buffer-based solutions (OFX and ReNu) resulted in a significant decrease in viability for LA and 
BA. A 20% reduction or more was seen at 8 hours with LA soaked in OFX and ReNu (p < 
0.001) as well as with LA soaked in Solo (p = 0.047) (Figure 4.1). Incubation for 8 hours in the 
presence of lenses soaked in Complete and PBS did not significantly reduce viability.  As 
illustrated in Figure 4.2, BA lenses soaked in OFX and ReNu also significantly reduced cell 
viability after 8 hours of incubation (p < 0.025). Further analysis comparing viability results and 
lens type showed that there was no significant effect of lens type at 8 hours (p > 0.05).   
After 24 hours, further decrease in viability was observed with MPS-soaked lenses.  As 
opposed to 8 hours, OFX and ReNu-soaked LA lenses led to different levels of viability (Figure 
1). The increased exposure time to OFX-soaked LA lenses significantly decreased cell viability 
down to 49% (p = 0.0001), while viability of cells exposed to ReNu-soaked LA only decreased 
slightly and remained around 65% viability. Cells exposed to LA lenses soaked in Solo and 
Complete had levels similar to viability at 8 hours. A significant decrease in viability was 
observed in BA lenses, with OFX, Solo, and ReNu, as compared to controls at 24 hours (p < 
0.002).  
At 24 hours, lens type did have a significant effect on viability. While there were similar 
trends in viability with both lenses, there was a significant difference in the viability of cells 
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exposed to OFX at 24 hours. LA-OFX had significantly lower viability compared to BA lenses 
soaked in the same solution (p = 0.022). Unlike LA-OFX, increased exposure time to OFX-
soaked BA lenses did not significantly reduce viability further when compared to the 8-hour time 


























Figure 4.1: HCEC viability after 8 and 24 hour contact with Lotrafilcon A lenses (LA) soaked in 
various MPS. Viability was measured by MTT assay and is expressed as a percentage relative to 
cells grown in the absence of lenses. N = 3 to 6, * Significantly different from cells grown in the 
absence of a lens (p < 0.04), # Significantly different from 8 hours (p < 0.03).  
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Figure 4.2: HCEC viability after 8 and 24 hour contact with Balafilcon A (BA) lenses soaked in 
various MPS. Viability was measured by MTT assay and is expressed as a percentage relative to 
cells grown in the absence of a lens. N = 3 to 6, * Significantly different from cells grown in the 
absence of lenses (p < 0.04), # Significantly different from 8 hours (p < 0.03).  





Precycling of Lens Cases 
The MTT assay was also used to determine whether there was a difference in viability 
between lenses soaked in cycled lenses case, with the appropriate MPS, or in a sterile 12-well 
polystyrene plate. Results demonstrated that there was no difference in HCEC viability due to 
the different lens soaking strategies (Figure 4.3); therefore, from this point onwards, all studies 
used sterile polystyrene plates for lens soaking to prevent potential contaminations. 
 
Figure 4.3: HCEC viability after 24 hour contact with Balafilcon A (BA) lenses soaked in 
various MPS in cycled lens cases and sterile polystyrene wells. Viability was measured by MTT 
assay and is expressed as a percentage relative to cells grown in the absence of a lens. N = 3. 





Cell Integrin Expression 
To assess the cell adhesion phenotype, flow cytometric studies were performed on 
adherent cells following 8 and 24 hour contact with MPS-soaked LA and BA lenses. As 
illustrated in Figure 4.4, after 24 hour contact, significant downregulation of α3 (CD49c) was 


























Figure 4.4: HCEC α3 expression after 24 hour contact with Lotrafilcon A (LA) and Balafilcon A 
(BA) lenses soaked in various MPS. Integrin expression was measured by flow cytometry and is 
expressed as a percentage relative to cells grown in the absence of a lens.  
N = 4 to 5, * Significantly different from cells grown in the absence of lenses (p ≤ 0.004). 
Complete, Complete Moisture Plus; OFX, Opti-Free Express; ReNu, ReNu MultiPlus; Solo, SoloCare 
Aqua  
 
As opposed to LA lenses, BA lenses soaked in Solo also led to a downregulation of β1 
(Table 4.2) at 24 hours.  Significant decrease in the expression of β1 (CD29) and β4 (CD104) 
were also observed with OFX and ReNu-soaked lenses (p < 0.04, Table 4.2). Similar to the 
viability results, a further decrease was seen in integrin expression after a 24-hour incubation 
time (p < 0.04, Table 4.2). The observed downregulation of integrins suggest that HCEC 
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adhesion phenotype was compromised in the presence of lenses soaked in the borate buffer based 
solutions. 
Table 4.2: Down regulation of integrin expression induced by contact with MPS-soaked lenses 
after 8 and 24 hours.  β1 and β4 expression were measured by flow cytometry and are expressed 
as a percentage relative to control (cells incubated in the absence of a lens). N = 4 to 5. 
 
  β1 β4 
Lens Solution 8 hrs 24hrs 8hrs 24 hrs 
Solo 88 ± 4 88 ± 8 96 ± 5 98 ± 4 
OFX 79 ± 4* 58 ± 4* 91 ± 6 67 ± 5* # 
Renu 77 ± 5* 63 ± 10* 93 ± 4 76 ± 5* # 




PBS 98 ± 5 94 ± 4 101 ± 5 99 ± 3 
Solo 88 ± 4 73 ± 6* 98 ± 5 92 ± 6 
OFX 78 ± 3* 57 ± 6* # 88 ± 5 68 ± 8* # 
Renu 79 ± 4* 56 ± 5* # 87 ± 5 70 ± 4* # 




PBS 103 ± 6 97 ± 4 98 ± 2 97 ± 2 
* Significantly different from cells incubated with PBS-soaked lens (p < 0.003). # Significantly different 
from 8hrs-soaked lens value (p ≤ 0.02). 





Activated caspases were detected by flow cytometry with the fluorescently-labelled pan 
caspase inhibitor, FITC-VAD-FMK.20 Increased fluorescence intensity can be observed in the 
presence of activated caspases, resulting in a bimodal distribution of fluorescence (as observed in 
Figure 4.5).  No significant caspase activation was detected prior to 24 hours (data not shown).  
Caspase activation was observed at 24 hours with LA lenses soaked in OFX by detecting a 
significant amount of cells staining positive for caspases (p < 0.012) (Figure 4.6). The caspase 
activation detected in cells exposed to OFX-BA was significantly lower than OFX-LA (p < 
0.015). While the cell viability data showed reduced viability with ReNu-soaked lenses, 
suggesting the potential for inducing cell apoptosis, no significant increase in caspase positive 







Figure 4.5: Histograms of HCEC caspase activation induced by MPS-soaked contact lenses. 
FITC-VAD-FMK fluorescent intensity was measured by flow cytometry after 24 hour exposure 
to Lotrafilcon A (LA) and Balafilcon A (BA) lenses soaked in MPS. Cross-hatched curve 
represents the fluoresecent intensity observed with MPS-soaked lens and overlaid dark line 
represents the negative control, PBS-soaked lens.  Histograms are representative of all 
experiments performed (N = 3 to 4).  



































Figure 4.6: HCEC caspase activation after 24 hour contact with Lotrafilcon A (LA) and 
Balafilcon A (BA) lenses soaked in various MPS. Activation was measured by flow cytometry 
and the percentage of cells staining positive for caspase activation is reported. N = 3 to 4, * 
Significantly different from cells grown in the absence of a lens (p < 0.012), # Significantly 
different from BA (p < 0.015).  






The in vitro contact lens “onlay” model reported in this thesis appears to be a valuable 
tool to study the direct release of multipurpose solutions on corneal epithelial cells. While 
blinking and the constant regeneration of the tear film may dilute the effects of the biocides in 
vivo, the uptake and slow release of MPS by the lens will increase the exposure time to the 
cornea, which further warrants the importance of evaluating solution release from a contact lens 
in vitro.  Table 4.3 summarizes the results obtained in this study.   
In this study, the results indicate that a scale of cytotoxicity can be derived among the 
commercially available MPS tested. The results obtained from cell contact with lenses soaked in 
phosphate buffer demonstrated near 100% viability and no change in cell adhesion phenotype 
and thus confirmed the validity of our in vitro model. Complete MPS demonstrated results 
similar to PBS, while OFX, ReNu and Solo demonstrated a significant adverse effect on 
viability. With the two SH lenses tested in this study, in vitro results demonstrated the following 
scale of corneal cell cytotoxicity: PBS < Complete < Solo < ReNu < OFX.  Our cytotoxicity 
scale, based on MPS solution released from contact lenses, is in accordance with previous studies 
where MPS was added directly to a monolayer of corneal cells.5,6   
As a consequence of being exposed to cytotoxic MPS, we hypothesized that this may 
lead to a compromised corneal monolayer in vitro. The flow cytometry results confirmed this 
concept. The integrins examined have strong roles in epithelial cell adhesion. α3, which 
heterodimerizes exclusively with β1, is important in the maintenance of cell-cell junctions.21 It is 
also involved in cell spreading and hemidesmosome stability.21-22 β4 is also an important 
component of hemidesmosomes.21-22 Expression of this integrin is crucial for stable adhesion of 
epithelium to the basement membrane.21 Significant reduction in integrin expression were 
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observed with lenses soaked in OFX and ReNu, suggesting that HCEC adhesion phenotype was 
being disrupted.   Our results are in agreement with a recent in vitro study showing that exposure 
to MPS, including OFX, caused a disruption in the structure of corneal epithelial tight junctions 
in vitro.29  
As previous studies have suggested, the disinfection agent present in the care regimen 
may be responsible for the observed cytotoxic effect on cells.16, 17, 24-28  However, both  OFX and 
ReNu led to reduced cell viability and integrin expression, but their disinfecting agent is different 
(Polyquad®/Aldox® versus PHMB).  Moreover, Complete also uses PHMB as a disinfecting 
agent, but viability and adhesion phenotype were not significantly affected by the solution when 
LA lenses were used.  Complete is buffered with a phosphate solution, while both ReNu and 
OFX are buffered with a borate solution, suggesting the buffering agent may have a significant 
effect on the biocompatibility property of MPS.  The findings that borate buffer has a significant 
effect on corneal cells are consistent with previous work in our laboratory, which found a 
significant decrease in viability, β1 and α3 with borate buffered contact lens packaging solutions.7  
In addition, Imayasu et al, also found that borate buffer had a negative effect on corneal tight 
junctions.29 Further studies in which  various individual ingredients in MPS are investigated to 
determine their potential cytotoxic effects in the presence of borate versus phosphate buffers 
would be worthy. 
Most in vitro studies with MPS have been limited to studying the effect of solutions on 
cells.4-6, 16,17, 27-29  A difference in cell viability observed at 24 hours with lenses soaked in OFX 
emphasizes the importance of testing solution-lens combinations in vitro. The difference in 
viability and adhesion phenotype may be attributed to the different physical properties of the 
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lenses. BA and LA lenses have different surface treatments: LA lenses are plasma-coated while 
BA lenses undergo plasma oxidation. This difference, which may affect the uptake and/or release 
of biocides from the lens and the actual concentration of MPS the cells are exposed to, had a 
significant effect on cells.  Further studies are currently underway to better understand the 
interaction between MPS solution, surface treatment on silicone hydrogel lenses and the effect 
on cells.    
Based on the findings from the viability and cell adhesion assays, it was hypothesized 
that the borate solutions were capable of inducing apoptosis. Apoptosis is a highly regulated, 
programmed cell death pathway, mediated in part by the actions of caspases.30 Caspases are 
cysteine proteases, normally found in the inactive, pro-caspase form. Initiation of apoptosis 
occurs upon activation of initiator caspases by intrinsic or extrinsic factors, which can 
subsequently activate downstream effector caspases. Apoptosis is characterized by several 
morphological features, such as membrane blebbing, cell shrinkage and chromatin condensation, 
which are the results of activated effector caspases.30,31 It was observed that OFX-soaked LA 
lenses  caused an increase in the number of cells staining positive for active caspases (p < 0.04), 
but the same was not true for OFX-soaked BA or ReNu-soaked LA lenses. Several hypotheses 
can be formed from this latter result.  ReNu may be causing necrosis in HCECs, but since the 
integrin expression was shown to be adversely affected by ReNu, it was expected that the cells 
exposed to both borate solutions were undergoing an apoptotic pathway.  It is plausible that 
ReNu is inducing a caspase-independent apoptotic pathway, or that the induction of apoptotic 
pathways by ReNu is on a different time-scale compared to OFX. If ReNu induces a more rapid 
apoptotic pathway, HCEC would have entered secondary necrosis. If ReNu induces a slower 
apoptotic pathway, HCEC may still be in the early phase of apoptosis, prior to caspase 
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activation. Both scenarios would explain the absence of activated caspases at 24 hours.  The fact 
that the OFX-soaked BA lens did not induce significant caspase activation further indicates MPS 
interaction with lens material and how uptake and release of MPS from SH lens may affect 
mechanism of cell activation.  Our caspase results further emphasize the importance of testing 
MPS-lens combinations when determining the biocompatibility of MPS.  
Our OFX results with LA lens support the findings of Dutot et al,17 showing that OFX 
induced apoptosis in conjunctival cells by upregulation of caspase 3. While other studies32 have 
correlated their findings to the OFX observation, this study is the first to specifically assess 
caspase activation in corneal cells exposed to MPS in vitro. DNA fragmentation assays cannot 
differentiate between apoptosis and necrosis and thus, while previous studies suggest a cytotoxic 
effect, it is difficult to infer the potential role for a caspase-mediated apoptosis pathway with 
such an assay.  Dutot et al also demonstrated the upregulation of caspase 3 in conjunctival cells 
by Solo. Such a result was not observed in our in vitro model with corneal epithelial cells.This 
suggests that corneal cells and conjunctival cells may have different physiological responses to 
MPS-induced toxicity and that the release from a lens versus direct solution test may also 
contribute to potential differences in cellular mechanisms. 
In summary, the results from this study shows that for MPS-released from a contact lens, 
a scale for in vitro corneal cell cytotoxicity can be derived, where the borate based MPS are the 
most cytotoxic and the phosphate based MPS are least cytotoxic. As demonstrated by the 
absence of an effect on cells exposed to a PBS-soaked lens, our results indicate that it is not the 
presence of the lens that affects cell viability and phenotype, but what is being released from the 
lens. The in vitro model also demonstrated a lens effect in the mechanism of MPS-induced 
76 
 
cytotoxicity. The differences in physical properties of BA and LA lenses, which affect the uptake 
and/or release of the various ingredients in MPS, had a significant effect on viability,  adhesion 
phenotype and caspase activation. The caspase results indicate that ReNu may induce apoptosis 
through a caspase-independent pathway, whereas OFX-induced apoptosis is caspase dependent.  
Further studies are under way to gain a better understanding of the preferential adsorption or 
release profile of certain compounds by silicone hydrogel lenses with different physical 




Table 4.3: Summary of the impact of lens-solution interaction on corneal epithelial cells in vitro 
  SoloCare ReNu Complete OptiFree Express 
 PHMB PHMB PHMB Polyquad/Aldox 

































No significant change compared to controls (cells grown in the absence of a lens or contact with PBS-soaked lens) 
Decrease compared to controls (cells grown in the absence of a lens or contact with PBS-soaked lens) 
Increase compared to controls (cells grown in the absence of a lens or contact with PBS-soaked lens) 








INVESTIGATING MECHANISMS OF SILICONE HYDROGEL LENSES SOAKED IN 
MULTIPURPOSE SOLUTION INDUCED APOPTOTIC PATHWAYS IN HUMAN CORNEAL 
EPITHELIAL CELLS, IN VITRO 
INTRODUCTION 
Evidence has shown that exposure to MPS, and certain lens-solution combinations, can cause 
cell death in vitro.1-5 It is has been hypothesized that the cell death pathway is a caspase-mediated 
apoptotic pathway.5,6 The use of DNA fragmentation assays is common7, but this assay cannot 
differentiate between apoptosis and necrosis and thus; while previous studies suggest a cytotoxic 
effect, it is difficult to infer the potential role for a caspase-mediated apoptosis pathway with such an 
assay. 
Apoptosis is a programmed form of cell death that has been evolutionarily conserved among 
multicellular organisms.8-11 It plays a role in several normal physiological process such as embryonic 
development, tissue homeostasis, and self-organizational processes in the immune system and central 
nervous system.10-12 It also serves as a defense mechanism in its role of removal of damaged cells.10-12 
This form of cell death has several morphologically recognizable features, including cytoplasmic 
shrinkage, plasma membrane blebbing, compaction of nuclear chromatin formation of vesicles and 
apoptotic bodies, and rapid cleavage of DNA into 180bp fragments, corresponding to internucleosomal 
spacing.8,10,11 There are two main distinct molecular signaling pathways that lead to apoptotic cell 




pathway (Figure 5.1).9 Both signaling pathways involve cysteine aspartate proteases (caspase) as 
mediators for initiating cellular disassembly.9,11  
Necrosis is a form of cell death considered to be accidental or inappropriate, which occurs 
under extremely unfavorable conditions. It is an uncontrollable, irreversible form of cell death 
characterized by cell swelling, membrane deformation and organelle breakdown. It has not been 
determined whether signaling pathways mediate necrotic cell death.13 
Thus, to investigate the mechanisms of cell death induced by multipurpose solutions released 
from contact lenses, a model in which the contact lens was directly set onto a monolayer of HCEC was 
used and corneal cell viability, mitochondrial transmembrane potential, caspase 3 and 9 activity and 
Annexin-V/Propidium Iodide (PI) staining were assessed following exposure to the care-regimen 
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Figure 5.1: Flow chart of apoptotic events in the extrinsic and intrinsic pathways. Highlighted are 




MATERIALS AND METHODS 
Reagents and antibodies 
Keratinocyte serum free medium, growth supplement (Bovine Pituitary extract) and pen-strep 
solution were purchased from ScienCell.  All other cell culture reagents, Dulbecco’s minimum 
essential medium, fetal bovine serum, phosphate buffer saline and TriplExpress were purchased from 
Invitrogen (Burlington, Ontario, Canada).  Antibodies for annexin V and propidium iodide (PI) were 
obtained as part of the Vybrant Apoptosis Assay Kit also purchased from Invitrogen. 
Contact lenses and multipurpose solutions 
Three silicone hydrogel lens materials were tested: Lotrafilcon A (LA; CIBA Vision; Duluth, 
GA, USA), Lotrafilcon B (LB; CIBA Vision; Duluth, GA, USA), and Balafilcon A (BA; Bausch & 
Lomb, Rochester, NY, USA). All lenses were purchased in their original packaging, had a diameter 
between 14.0 and 14.2 mm and a curvature of 8.5 to 8.7mm. Four polyquaternium and biguanide 
preserved multipurpose solutions were tested and their composition is described in Table 5.1. 





Buffer Other reported agents (surfactants 
and  chelating agents) 
Opti-Free Express (OFX) Polyquad® 
0.001%, Aldox® 
0.0005% 
Borate Sorbitol; citrate (citric acid), 0.05% 
EDTA; poloxamine (Tetronic 1304) 





Borate Citrate, poloxamine (Tetronic 1304), 
non-anoyl ethylene-diaminetriacetic 
acid 
AMO Complete Moisture Plus 
(Complete) 
PHMB 0.0001% Phosphate Taurine; 0.01% EDTA; Poloxamer 






PHMB 0.0001% Borate Sodium borate; 
Hydroxyalkylphosphonate 
(Hydranate™); 0.1% EDTA; 
Poloxamine (Tetronic 1107) 
CIBA Vision SoloCare Aqua 
(Solo) 
PHMB 0.0001% Tris Sorbitol; 0.025% EDTA; 
dexpanthenol (provitamin B5); 
Pluronic F127 (poloxamer 407) 






In vitro cell culture 
Immortalized human corneal epithelial cells (HCEC) 
SV40-immortalized human corneal epithelial cells were cultured in keratinocyte serum free 
medium supplemented with bovine pituitary extract, recombinant epidermal growth factor and pen-
strep (KSFM).  Fresh medium was added every other day and cells were grown to 90% confluency in 
tissue culture treated flasks.  Adherent cells were removed using a dissociation solution, TriplExpress. 
Cells were routinely observed for any morphological changes.   
In vitro model 
A direct contact in vitro model was used.5,15 HCEC were seeded onto a 24 well tissue culture 
treated polystyrene (TCPS) plate at 105 cells per well.  Cells were left to adhere for 18-24 hours in a 
humid CO2 incubator, which resulted in the formation of a monolayer of HCEC. Simultaneously, 2 mL 
of MPS was added to the wells of a sterile 12-well polystyrene plate (BD Falcon, Mississauga, ON, 
Canada).  Using sterile tweezers, lenses were gently removed from their blister package and added to 
the wells containing MPS.  Lenses were totally immersed and left to soak for 18 – 24 hours. All lens-
solution soaking combinations were performed under sterile conditions. 
The next day, supernatant was removed from the cells and fresh serum-free medium (700 µL) 
was added. MPS-soaked SH lenses were placed gently on top of the monolayer, face-down, with the 
concave surface facing upwards and incubated for up to 24 hours at 37oC (5% CO2 in a humid 
incubator).  Lenses were totally immersed in medium.  After 24 hours, lenses were carefully removed 
from wells.  The lenses did not adhere to the HCEC monolayer.  Lenses were also routinely observed 




Cellular Loss (Cell Count) 
HCEC were harvested and resuspended in 200 µL of fresh serum-free medium. A 50 µL 
aliquot of cells was diluted in 5 mL of ISOTON II Diluent (Beckman Coulter Inc., Fullerton, CA, 
USA). Cell counts were determined using a Z2 Coulter Particle Counter and Size Analyzer (Beckman 
Coulter Inc., Fullerton, CA, USA). Healthy cells were counted in the range of 5.896µm – 20.85µm; 
dead/dying cells were counted below this range. The percentage of cell viability was calculated for 
each test solution and is expressed as relative viability compared to cells grown in the absence of a 
contact lens.  
MitoCapture Assay 
To determine mitochondrial transmembrane potential, MitoCapture Apoptosis Detection kit 
(Calbiochem, La Jolla, CA, USA) was used. Harvested cells, resuspended in MitoCapture reagent, 
were incubated for 20 minutes, at 37oC (5% CO2 in a humid incubator). Samples were then 
centrifuged, resuspended in 500 µL of pre-warmed incubation buffer and analysed immediately by 
flow cytometry. All samples were acquired on BD FACSCalibur flow cytometer (BD Biosciences, San 
Jose, CA, USA) using BD CELLQuest Pro Software. Appropriate isotype controls were used with 
each experiment. 
Caspase Proteolytic Enzyme Activity 
Proteolytic enzyme activity of caspase-3 (C3), and caspase-9 (C9) were determined in HCEC 
culture using the substrates, Ac-DEVD-AMC (Alexis Biochemicals, Burlington, ON, Canada), and 
Ac-LEHD-AMC (Alexis Biochemicals, Burlington, ON, Canada), respectively. Following treatment, 
HCEC were harvested and stored at -700C in the absence of growth medium, prior to use in the assay. 
Briefly, cultured HCEC was homogenized in ice-cold lysis buffer (20 mM HEPES, 10 mM NaCl, 1.5 




inhibitors and centrifuged at 1000 x g for 10 min at 4°C. Cell supernatants were then incubated with 
the appropriate substrate at room temperature for 1 hour. Fluorescence was measured using a 
SPECTRAmax Gemini XS microplate spectrofluorometer (Molecular Devices, Sunnyvale, CA, USA) 
with excitation and emission wavelengths of 360 nm and 440 nm, respectively. As a positive control 
for caspase proteolytic activity, the appropriate substrate was incubated with human recombinant 
active C3 (Alexis Biochemicals, Burlington, ON, Canada) or C9 (Alexis Biochemicals, Burlington, 
ON, Canada). In all cases, a strong fluorescent signal was obtained (data not shown).  Furthermore, 
control experiments using the C3, and C9 inhibitors, Ac-DEVD-CHO (Alexis Biochemicals, 
Burlington, ON, Canada), and Ac-LEHD-CHO (Alexis Biochemicals, Burlington, ON, Canada), 
respectively, completely inhibited the fluorescent signal observed from both the active recombinant 
enzymes as well as HCEC (data not shown). Caspase activity was normalized to total protein content 
and expressed as mean fluorescence intensity in AU per mg protein.  
Annexin V-FITC/Propidium Iodide Staining 
To evaluate plasma membrane expression of phosphatidylserine, and subsequently apoptosis, 
harvested cells were also used for flow cytometry, which was performed according to the Vybrant 
Apoptosis Kit, FITC annexin V/propidium iodide (Invitrogen, Burlington, ON, Canada). In brief, each 
cell suspension was washed with cold PBS and centrifuged at 1000 rpm for 5 min at 24oC. The cell 
pellet was resuspended in 100 µL of binding buffer. 5 µL of Annexin V-FITC solution and 1 µL of PI 
were added to each suspension. The suspension was incubated at room temperature for 15 minutes in 
the dark, and then diluted with 400 µL of binding buffer. Cell suspensions were analyzed by flow 
cytometry immediately. All samples were acquired on BD FACSCalibur flow cytometer (BD 
Biosciences, San Jose, CA, USA) using BD CELLQuest Pro Software. Appropriate isotype controls 





All results are reported as means ± standard deviation (SD). Analysis was performed using 
FCSExpress post data acquisition. To evaluate the significance of the differences in cell viability, 
mitochondrial transmembrane potential, caspase activity and Annexin V-FITC/PI staining, an ANOVA 
was carried out followed by a post hoc Bonferroni test using Statistica.  A p value of less than 0.05 was 
required for statistical significance.  The number of experiments was equal to or greater than three with 






Cell Loss (Cell Count) 
Cell viability was assessed after incubation periods of 24 hours. There was no significant 
difference in cell count between cells incubated in the absence of a lens and cells incubated with a 
PBS-soaked lens (p = 1.000). The borate buffer-based solutions (OFX and ReNu) resulted in a 
significant decrease in viability for LA lenses. A 50% reduction was seen with LA soaked in OFX (p = 
0.0002), while LA-ReNu led to a 30% reduction, which was significantly different from the positive 
PBS control (p < 0.05) (Figure 5.2). LA lenses soaked in OFX and ReNu also demonstrated the 
greatest number of dead/dying cells (Figure 5.3), as indicated by the number of cells counted in the 
size range below 11.38 µm. Incubation in the presence of lenses soaked in Complete, Solo and PBS 
did not significantly reduce viability.  As illustrated in Figure 2, BA lenses soaked in OFX and ReNu 
also reduced cell count, at 63% and 71%, respectively (p < 0.05). 
 
Figure 5.2: HCEC count of healthy cells after 24 hour contact with Lotrafilcon A and Balafilcon A 
lenses soaked in various MPS. Viability was measured by cell count and is expressed as a percentage 
relative to cells grown in the absence of lenses. N = 3 to 4, * Significantly different from cells grown 
in the absence of lenses (p < 0.05), # Significantly different from Balafilcon A (p < 0.0006). 







Figure 5.3: HCEC count of dying cells after 24 hour contact with Lotrafilcon A and Balafilcon A 
lenses soaked in various MPS. Viability was measured by cell count and is expressed as a percentage 
relative to cells grown in the absence of lenses. N = 2 to 3. 
Complete, Complete Moisture Plus; OFX, Opti-Free Express; ReNu, ReNu MultiPlus; Solo, SoloCare Aqua  
 
Similar results were obtained using an MTT assay, as previously described in Chapter 4, with 
the exception of Solo, which previously was found to have significant lower viability compared to 
controls at 24 hours. The cell count did not detect a significant cell loss for LA or BA lenses soaked in 
Solo. The greatest reduction of cell viability was from LA-OFX at 49%, while both LA and BA soaked 
in Complete had levels similar to controls, at 88% and 79% respectively.  
Lens type did have a significant effect on viability. While there were similar trends in viability 
with both lenses, there was a significant difference in the viability of cells exposed to OFX at 24 hours. 
LA-OFX had significantly lower viability compared to BA lenses soaked in the same solution (p = 
0.0006). 
Mitochondrial membrane potential 
Alterations in the mitochondrial membrane potential were detected by flow cytometry with the 




aggregates of the MitoCapture reagent, which can be detected using the FL2 or FL3 channel.16 In 
apoptotic cells, the MitoCapture reagent cannot aggregate in the mitochondria due to the altered 
mitochondrial membrane potential, and thus it remains in its fluorescent green monomeric form, to be 
detected using the FL1 channel (Figure 5.3).16 The resulting changes in membrane potential are 
reported as the mean ratio of red:green cells in Table 5.2. While LA-OFX had the lowest red:green 






























Figure 5.3: Changes in HCEC mitochondrial transmembrane potential by MPS-soaked contact lenses. 
Figures represent one trial, after 24 hour exposure to Lotrafilcon A soaked in Opti-Free Express (right) 
and no lens (left). Red staining represents living cells, with healthy mitochondria; green staining 
represents apoptotic cells, with altered mitochondrial transmembrane potential. 
Table 5.2: Ratio of MitoCapture reagent fluorescence representative of alterations of the mitochondrial 







Lens  Solution Red:Green  SD 
   Solo  2.45  0.91 
   OFX  1.6  0.51 
LA  ReNu  2.57  0.86 
   OFR  2.11  0.62 
   PBS  2.07  0.84 
   Solo  2.27  0.5 
   OFX  2.12  0.58 
BA  ReNu  2.33  0.74 
   OFR  1.96  0.88 





Caspase Proteolytic Enzyme Activity 
Activated caspases were detected by fluorescence with the substrates, Ac-DEVD-AMC and 
Ac-LEHD-AMC. These fluorogenic substrates are weakly fluorescent but yield highly fluorescent 
products following proteolytic cleavage by their corresponding active caspase enzyme.  Increased 
fluorescence intensity can be observed in the presence of activated caspases.  
C3 activation was observed at 24 hours with LA lenses soaked in OFX by detecting a 
significant increase in fluorescence at 29.57AU per mg protein (Figure 5.4), resulting in a 315% 
increase relative to cells grown in the absence of a lens (p = 0.00002) and all other solution-lens 
combinations (p < 0.02). The C3 activation detected in cells exposed to BA-OFX was significantly 
lower than LA-OFX (p = 0.0199). No significant upregulation of C3 was detected with any other 
solution-lens combination.  In addition, significant levels of C9 were also not detected (Table 5.3). 
 
 
Figure 5.4: Caspase 3 activity after 24 hour contact with Lotrafilcon A and Balafilcon A lenses soaked 
in various MPS. Caspase activity was normalized to total protein content and expressed as mean 
fluorescence intensity in AU per mg protein. N = 3 to 4, * Significantly different from cells grown in 
the absence of lenses (p < 0.05), # Significantly different from Balafilcon A (p < 0.02). 





Table 5.3: Caspase 9 (C9) activity after 24 hour exposure to lens solution treatments, as measured by 
fluorescence. Caspase activity was normalized to total protein content and expressed as mean 




   Solo  8.66  3.1 






   Solo  7.07  4.4 
   OFX  11.41  6.8 
 BA  OFR  4.30  4.7 
  ReNu  10.59  6.0 





Annexin V-FITC/Propidium Iodide Staining 
To assess apoptosis and necrosis, Annexin V-FITC/PI staining was detected using flow 
cytometry. Post analysis using FCSExpress was used to determine the percentage of healthy cells (not 
stained), apoptotic cells (stained with Annexin V-FITC only), early necrotic cells (stained with PI 
only), and secondary necrotic cells (stained with both Annexin V-FITC and PI) (Figure 5.5). When 
cells were grown in the absence of a lens, 0.4, 2.2 and 1.2% of cells were stained with Annexin V-
FITC, PI and both, respectively. This indicated that 96.2% of cells remained healthy, as the cells 
stained neither with annexin V nor PI. Exposure to OFX resulted in significant populations of 
apoptotic and early necrotic cells (Table 5.4). LA-OFX had 14.4% early necrotic cells, and 2.1% 
apoptotic cells (p < 0.013). LA-OFR had similar results, with 7.6% of cells in early necrosis and 2.1% 
of cells in apoptosis, but only the apoptotic population was significantly different from control cells 
grown in the absence of a lens (p = 0.0002). While both LA-OFX and OFR induced 4% of the cell 
population to enter secondary necrosis, this value was not significant. No solution combination with 
BA lenses yielded a significant effect. LB lenses were also tested to further compare the effects of lens 
material and surface treatment.  LB-OFX also demonstrated similar significant levels of apoptotic 




Table 5.4: Apoptotic effects of lens-solution treatments as detected by flow cytometry (mean ± SD, n = 














Solo  96.4 ± 1.7  0.5 ± 0.2  1.8 ± 1.3  1.3 ± 0.5 
OFX  79.5 ± 8.7*  2.1 ± 1.4*  14.4 ± 9.6*  4.0 ± 0.5 
OFR  85.7 ± 6.4*  2.6 ± 1.8*  7.6 ± 3.4  4.1 ± 3.3 
ReNu  95.5 ± 2.0  0.5 ± 0.3  2.6 ± 0.9  1.5 ± 0.9 
LA 
PBS  97.1 ± 1.1  0.4 ± 0.2  1.4 ± 0.7  1.1 ± 0.2 
Solo  96.0 ± 2.3  0.5 ± 0.4  2.4 ± 2.2  1.1 ± 0.6 
OFX  91.5 ± 2.8  1.4 ± 1.2  4.2 ± 1.9  2.9 ± 2.3 
OFR  94.4 ± 1.3  0.9 ± 0.5  3.3 ± 1.0  1.4 ± 0.4 
ReNu  96.6 ± 1.2  0.3 ± 0.1  1.9 ± 0.6  1.2 ± 0.8 
BA 
PBS  97.1 ± 1.3  0.5 ± 0.2  1.3 ± 0.6  1.2 ± 0.6 
Solo  91.8 ± 4.8  0.8 ± 0.6  3.5 ± 1.0  3.9 ± 4.1 
OFX  83.9 ± 2.3  2.9 ± 2.4*  7.8 ± 5.4  5.4 ± 4.5 
OFR  91.9 ± 1.5  0.7 ± 0.2  6.4 ± 1.2  1.1 ± 0.1 
ReNu  90.0 ± 2.5  0.4 ± 0.4  8.2 ± 2.9  1.3 ± 0.1 
LB 
PBS  90.2 ± 4.3  0.4 ± 0.5  5.9 ± 1.2  3.5 ± 3.9 
OFX  91.0 ± 2.5  0.9 ± 0.5  4.6 ± 1.9  3.5 ± 1.1 
OFR  92.4 ± 3.2  0.7 ± 0.7  4.3 ± 2.6  2.6 ± 2.6 
10% 
dilution 
ReNu  91.6 ± 4.3  0.3 ± 0.2  6.9 ± 4.4  1.2 ± 0.4 
No Lens  96.2 ± 1.5  0.4 ± 0.3  2.2 ± 1.4  1.2 ± 0.4 
Controls 
Alcohol  65.3 ± 7.5*  1.4 ± 0.7  22.1 ± 4.6*  11.2 ± 4.5 
 













































































Figure 5.5: Annexin V-FITC/PI staining induced by MPS-soaked contact lenses. Figures represent one trial, after 24 hour exposure to Lotrafilcon 
A, Lotrafilcon B and Balafilcon A lenses soaked in MPS. Cell populations in the lower left quadrant are healthy cells (not stained), lower right 
quadrant are apoptotic cells (stained with Annexin V-FITC only), upper left quadrant are early necrotic cells (stained with PI only), and upper 
right quadrant are late/secondary necrotic cells (stained with both Annexin V-FITC and PI). Cells exposed to 10% alcohol represent positive 





The results obtained from cell contact with lenses soaked in phosphate buffer demonstrated 
near 100% viability and no change in caspase activation or annexin V staining and thus confirmed the 
validity of our in vitro model. The cell count results are in agreement with previously published 
cellular viability results, obtained from an MTT assay. While there were no significant differences in 
viability between the assays, the MTT assay appeared to be more sensitive in detecting changes in 
mitochondrial function rather than cell loss, as it detected a significant decrease in cells exposed to 
both lenses soaked in ReNu and Solo, at 24 hours.  
One of the early events of the intrinsic pathway of apoptosis is alteration of mitochondrial 
transmembrane potential.9,12,17,18 While the MitoCapture assay did not demonstrate a significant 
change in mitochondrial transmembrane potential, the trend was that more cytotoxic solution-lens 
combinations, such as LA-OFX, as determined by the cell count and previous cytotoxicity testing, had 
the most reduction in membrane potential. When apoptotic stimuli disrupt the mitochondrial 
transmembrane potential, it triggers the release of cytotchrome c (cyt c) from the intermembrane space, 
leading to activation of C9 and intrinsic activation of apoptosis.11,12,17,18 Cyt c in the cytoplasm can 
bind Apaf-1 (apoptotic protease activating factor-1), a scaffolding molecule key to the formation of the 
apoptosome.11,19 Cyt c will induce a nucleoside triphosphate-dependent conformational change, 
allowing for the binding of procaspase-9.20-25 Procaspase-9 is the initiator caspase of the intrinsic 
pathway of apoptosis.26,27 It is a monomer with misaligned catalytic cysteine and histidine residues and 
an inactive catalytic pocket.26,27 The complex of cyt c, Apaf-1 and procaspase-9 forms the apoptosome, 
which leads to the activation of C9 by conformational changes that open the catalytic pocket and align 
the catalytic residues.27 While the results of the C9 activity assay were also not significant, the trend 




performed at the same time point of 24 hours, which appears to correlate better with the mid phase 
apoptotic events. The alteration of mitochondrial membrane potential and activation of C9 are early 
phase apoptotic events9; if evaluated at earlier time points, mitochondrial potential and C9 activity may 
be significant. 
Previous work has shown that the combination of LA lenses and OFX solution caused an 
upregulation of caspases, as detected by a pancaspase assay. Findings from this study confirm that this 
is primarily due to upregulation of downstream effector C3 at 24 hours. Evidence of initiator C9 
activity and altered mitochondrial membrane potential, and absence of activation of Fas death 
receptors (data not shown), suggests that apoptosis induced by LA-OFX is through the intrinsic 
pathway. C3 activation was also observed in human conjunctival cells, when exposed to OFX.6 The 
study also found that Solo significantly induced C3 activity, which is contrary to the findings of this 
study.6 The discrepancy may be due to the concentration of MPS the cells were exposed to, or the 
difference in cell type. The release of biocides from a contact lens is likely a low concentration, so by 
using the MPS directly grossly overestimates the concentration the ocular surface would normally be 
exposed to. Evidence has also shown that certain combinations of MPS and silicone hydrogel lenses 
can lead to a cytotoxic effect in vitro 1-3 and some combinations have the potential to exhibit excessive 
corneal staining in vivo, further supporting the importance of using contact lenses in MPS cytotoxicity 
testing.39-47 While conjunctival cells also have the potential to exhibit adverse reactions following 
contact lens wear, the contact lens and released MPS come into the most contact with the corneal 
epithelium.48 If the difference is due to cell type, rather than concentration, conjunctival cells should be 
considered an inappropriate proxy for corneal epithelial cells, when investigating MPS cytotoxicity.  
Previously, it was hypothesized that the borate solutions, OFX and ReNu, were capable of 




cells staining positive for Annexin V-FITC and PI, indicating significant populations of apoptotic and 
early necrotic cells. The presence of Annexin V staining indicates that the phospholipid scramblase 
was activated by cleavage of Cδ, and PS is being expressed on the plasma membrane surface as a 
signal that can be recognized by the adaptor molecule MFG-E8 on adjacent cells and/or a PS receptor 
present on macrophages, facilitating phagocytosis of the dying cells.34-38 These findings may be related 
to recent in vivo observations where LA lenses in combination with Opti-Free MPS was associated 
with a significantly higher incidence of corneal infiltrative events.47 Exposure to dilute ReNu showed a 
greater amount of PI staining compared to Annexin V staining, indicating a pure necrotic response, 
rather than an apoptotic response. Previously, it was hypothesized that both borate solutions, including 
ReNu, may be causing apoptosis in HCECs, due to evidence that integrin expression was adversely 
affected by ReNu. Upon further investigation, the results from this study indicate that apoptosis is not 
likely to be induced by ReNu. Since both solutions are borate based, borate is also likely to not cause 
apoptosis. Borate has been shown to cause cell death, and the results from this study indicate a 
potential role in necrosis.3,5,15 It is likely that other constituents of OFX are acting as the apoptotic 
stimuli. Many studies have attributed the cytotoxicity potential of OFX to its active ingredient, 
Polyquaternium-1 (PQ), a quarternary ammonium, which targets bacterial cytoplasmic and fungal 
plasma membranes.1,2,48-50 Studies have shown that after interaction with lenses during the overnight 
disinfection cycle, OFX (and OFR) solution retains their bactericidal and fungicidal activity; while 
ReNu (PHMB) does not.50 While it is ideal to retain this property, it means that residual active 
disinfecting agents on lenses have the potential to interact adversely with the corneal surface.50 The 
added effect of borate in OFX may also contribute to cell death, but through a necrotic pathway rather 
than apoptosis. ReNu showed a significant decrease in both the activity and PHMB biocide 




containing other active constituents such as borate, is responsible for necrosis. The surfactants in OFX 
may also be responsible for the cytotoxicity, since the newest Opti-Free solution, RepleniSH, has a 
new TearGLYDE surfactant system. While OFR still contains Polyquad, the difference is in the 
surfactant system. Unlike OFX, OFR did not significantly affect C3 activity. In addition, the absence 
of EDTA in Opti-Free RepleniSH may account for differences between the two Opti-Free solutions. 
It was found that lens type also played a role in inducing apoptosis, where only LA soaked in 
OFX significantly affected C3 activation and Annexin V/PI staining. The difference may be attributed 
to the different physical properties of the lenses. BA and LA lenses have different surface treatments: 
LA lenses are plasma coated while BA lenses undergo plasma oxidation.51 This difference, which may 
affect the uptake and/or release of biocides from the lens and the actual concentration of MPS the cells 
are exposed to, had a significant effect on cells. This theory was supported by the Annexin V-FITC 
staining demonstrated by OFX released from LB lenses, which was similar to levels seen with LA 
lenses. While they are different materials, LB has the same plasma surface coating which LA lenses 
possess, indicating that the surface treatment may be one of the lens parameters affecting uptake and 
release. Levels of PI staining were however much lower with LB-OFX than with LA-OFX suggesting 
that other lens parameters, such as lens chemistry, can also influence lens adsorption and release 
profiles and hence will affect cell response. Additionally, one must consider the ability of the lens 
material to form a complex with constituents of MPS, which would affect the way in which cytotoxic 
constituents are exposed to the epithelial surface.52 Further studies are currently underway to better 
understand the interaction between MPS solution, surface treatment on silicone hydrogel lenses and 




In summary, the results from this study shows that for MPS-released from a contact lens, 
mechanisms of cell death can be investigated. As demonstrated by the absence of an effect on cells 
exposed to a PBS-soaked lens, our results indicate that it is not the presence of the lens that affects cell 
viability and phenotype, but what is being released from the lens. The results indicate that OFX-
induced cell death is caspase mediated intrinsic apoptosis pathway, whereas the cell death induced by 
ReNu is necrosis.  The in vitro model also demonstrated a lens effect in the mechanism of MPS-
induced cell death pathways. The differences in physical properties of BA and LA lenses, which affect 
the uptake and/or release of the various ingredients in MPS, had a significant effect on viability, C3 
activation and Annexin V/PI staining. Further studies are under way to gain a better understanding of 
the preferential adsorption or release profile of certain compounds by silicone hydrogel lenses with 








IMPACT OF LENS MATERIAL ON CYTOTOXICITY POTENTIAL OF MULTIPURPOSE 
SOLUTIONS IN HCEC, IN VITRO 
INTRODUCTION 
After contact lens wear, lenses must be disinfected to prevent growth of harmful bacteria 
that may be present on the lens and remove lipid and/or protein deposits on lenses.1-4 The most 
commonly prescribed disinfection systems are multi-purpose solutions (MPS).3-5 MPS are single 
solutions, that are used to rinse, clean, disinfect, rewet and store contact lenses.1-4 MPS contain 
many different components to enhance disinfection and preservative properties. The disinfecting 
properties of MPS are conferred by the active biocide, which are commonly a polyquaternium, 
biguanide or hydrogen peroxide agent.6,7  The preservatives in MPS, such as Polyquad, Aldox and 
Polyhexamethylene biguanide (PHMB), are intended to breach cell walls of microbes, but may have 
the potential to cause corneal epithelial cell membrane toxicity.2,8 MPS also contain a buffering 
solution to maintain the pH of the solution, which is typically either borate or phosphate-based.7 The 
solution must be efficacious enough against microbial flora, but gentle enough to not cause adverse 
effects on the corneal surface, as some of the solution will be exposed to the corneal surface and 
remain in contact with the epithelium until washed away by the post-lens tear film.3-5  While some 
have hypothesized that, due to their high molecular weight, the disinfecting agents cannot penetrate 
the surface of the lens, one cannot ignore the potential of the lens to adsorb or form a complex with 
components of MPS and release them onto the corneal surface post insertion. 
Silicone hydrogel (SH)  lenses are the newest generation of contact lens materials, which 




properties of the chemical polymers used in hydrogel and siloxane-based contact lens materials 
allow for the potential adsorption and absorption of components of care regimens during the 
overnight disinfection cycle, followed by potential release onto the corneal surface during lens wear.  
Various surface modifications and proprietary chemistry are employed to reduce the hydrophobicity 
of the SH lens surface and the potential interaction of the lens with tear film components and active 
components of MPS.9,10 The surface of Lotrafilcon A (LA) and Lotrafilcon B (LB) lenses are 
permanently modified with a mixture of trimethyl-silane oxygen and methane, in a gas plasma 
reactive chamber.9,10 The resulting coating is continuous ultra-thin, hydrophilic surface. Balafilcon 
A (BA) lenses are treated in a gas plasma chamber to convert all siloxane components into silicate 
compounds, making the surface more hydrophilic.9,10 The transformed areas form ‘glassy islands’, 
which bridge over the underlying hydrophobic lens material.9,10 This differs from the surfaces of all 
other lenses tested, as it is the only lens with a relatively “rough”, discontinuous surface.9,10 The 
exposed bulk material makes the lens more hydrophobic in comparison to other SH lenses, which 
may collect more lipid and protein, and has higher contact angles.9,10  
Galyfilcon A (GA) and Comfilcon A (CA) are both non-surface treated lenses. In GA lenses, 
an internal wetting agent, derived from poly(vinylpyrrolidone), have been incorporated in the bulk 
material to improve hydrophilicity.9,10 To date, there is very little published on CA lenses. 
Proprietary chemistry is used to create a highly wettable surface, without specific surface 
modifications.9 The surface features are comparable to that of conventional polyHEMA lenses.9  
Despite modifications aimed to reduce adsorption and release of active biocides onto corneal 
surface, certain combinations of MPS and SH lenses can lead to a cytotoxic effect in vitro4,12-14 and 




observations, many biocompatibility studies have been undertaken to examine the effect of 
ophthalmic solutions, including contact lens packaging solutions and multipurpose solutions, on 
corneal and conjunctival cells.2-5,12,13,23-26 Most in vitro studies with MPS have been limited to 
studying the effect of solutions on cells, using extracts or dilutions of solutions to evaluate the 
corneal effect. These studies were able to evaluate the potential cytotoxic effect of ophthalmic and 
multipurpose solutions in vitro, and while this is valuable research, there is currently no information 
on the effect of the direct release of solutions from silicone hydrogel lenses on human corneal 
epithelial cell (HCEC).2-5,12,13,23-26 Previous studies have shown that lens type will affect uptake and 
release of compounds contained in MPS11, and this may also have an impact on any subsequent 
cytotoxic responses observed. Previously published data from our laboratory, which detected 
differences in cell viability and caspase activation at 24 hours with lenses soaked in OFX, 
emphasizes the importance of testing solution-lens combinations in vitro. The difference in viability 
and adhesion phenotype may be attributed to the different physical properties and surface treatments 
of the lenses. This difference, which may affect the uptake and/or release of biocides from the lens 
and the actual concentration of MPS the cells are exposed to, had a significant effect on cells.   
This study was undertaken to determine the effect that the surface properties of silicone 
hydrogel contact lenses have on the direct release of multipurpose solutions and understand the 




MATERIALS AND METHODS   
Reagents  
Keratinocyte serum free medium, growth supplement (Bovine Pituitary extract) and pen-
strep solution were purchased from ScienCell.  All other cell culture reagents, Dulbecco’s minimum 
essential medium, fetal bovine serum, phosphate buffer saline and TriplExpress were purchased 
from Invitrogen (Burlington, Ontario, Canada).   
Contact lenses and multipurpose solutions 
Six silicone hydrogel lens materials were tested (Table 6.1): balafilcon A (BA; Bausch & 
Lomb, Rochester, NY, USA), lotrafilcon A (LA; CIBA Vision; Duluth, GA, USA), lotrafilcon B 
(LB; CIBA Vision; Duluth, GA, USA), comfilcon A (CA; CooperVision; Fairport, NY, USA) and 
galyfilcon (GA; Vistakon; Jacksonville, FL, USA). All lenses were purchased in their original 
packaging, had a diameter between 14.0 and 14.2 mm and a curvature of 8.5 to 8.7mm. Four 




Table 6.1: Properties of lenses used in the study27  
 
 
Proprietary Name PureVision Focus Night & 
Day 
O2 Optix Biofinity Acuvue Advance 
Manufacturer Bausch & 
Lomb 
CIBA Vision CIBA Vision CooperVisi
on 
Vistakon (Johnson & 
Johnson) 





36 24 33 48 47 
Dk 99 140 110 128 60 
Charge Ionic Non-ionic Non-ionic Non-ionic Non-ionic 
Principle 
Monomers 
NVP + TPVC DMA + TRIS + 
siloxane 
macromer 
DMA + TRIS + 
siloxane 
macromer 
Undisclosed mPDMS + DMA + 
EGDMA + HEMA + 











None None, internal 
wetting agent 
 
DMA (N,N-dimethylacrylamide); EGDMA (ethyleneglycol dimethacrylate); HEMA (poly-2-hydroxyethyl methacrylate); mPDMS 
(monofunctional polydimethylsiloxane); NVP (N-vinyl pyrrolidone); PVP (polyvinyl pyrrolidone) TPVC (tris-(trimethylsiloxysilyl) 














Buffer Other reported agents 







Borate Sorbitol; citrate (citric acid), 
0.05% EDTA; poloxamine 





Borate Citrate, poloxamine (Tetronic 
1304), non-anoyl ethylene-
diaminetriacetic acid 
AMO Complete Moisture 
Plus 
(Complete) 
PHMB 0.0001% Phosphate Taurine; 0.01% EDTA; 
Poloxamer 237 (Pluronic F87); 





PHMB 0.0001% Borate Sodium borate; 
Hydroxyalkylphosphonate 
(Hydranate™); 0.1% EDTA; 
Poloxamine (Tetronic 1107) 
CIBA Vision SoloCare Aqua 
(Solo) 
PHMB 0.0001% Tris Sorbitol; 0.025% EDTA; 
dexpanthenol (provitamin B5); 
Pluronic F127 (poloxamer 407) 
 




In vitro cell culture 
Immortalized human corneal epithelial cells (HCEC) 
  SV40-immortalized human corneal epithelial cells were cultured in keratinocyte serum free 
medium supplemented with bovine pituitary extract, recombinant epidermal growth factor and pen-
strep (KSFM).  Fresh medium was added every other day and cells were grown to 90% confluency 
in tissue culture treated flasks.  Adherent cells were removed using a dissociation solution, 
TriplExpress (Sigma-Aldrich, Oakville, Ontario, Canada). Cells were routinely observed for any 
morphological changes.   
In vitro model 
 A direct contact in vitro model was used.7 Briefly, HCEC were seeded onto a 24 well tissue 
culture treated polystyrene (TCPS) plate at 105 cells per well.  Cells were left to adhere for 18-24 
hours in a humid CO2 incubator, which resulted in the formation of a monolayer of HCEC. 
Simultaneously, SH lenses were totally immersed in the four MPS, in a sterile 12-well polystyrene 
plate and soaked for 18 – 24 hours. All lens-solution soaking combinations were performed under 
sterile conditions. 
  Supernatant was then removed and fresh serum-free medium was added. MPS-soaked SH 
lenses were placed gently on top of the monolayer, face-down, with the concave surface facing 
upwards and incubated for up to 24 hours at 37oC (5% CO2 in a humid incubator).  Lenses were 
totally immersed in medium.  After 24 hours, lenses were carefully removed from wells.  The lenses 
did not adhere to the HCEC monolayer.  Lenses were also routinely observed for the presence of 




Additionally, cells were exposed to dilutions of MPS, between 0.1 – 10%, added to the 
medium for a 24 hour incubation period. 
Cellular viability 
To measure cytotoxicity of the products released from the contact lenses, the MTT cellular 
viability assay was performed.  After a gentle rinse in sterile PBS, cells were incubated with a 
solution of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT at 1mg/mL in 
KSFM medium).  After 3 hours at 37oC, cells were lysed with DMSO and absorbance read at 
595nm.  All results are expressed as relative viability compared to cells grown in the absence of a 
contact lens. 
Caspase activation 
To determine cellular activation by change in caspase activation induced by MPS release 
from contact lens, following a gentle wash in PBS, HCEC were removed from the wells with 
TriplExpress (Invitrogen, Burlington, Ontario, Canada). Cells were washed and resuspended in 
DMEM/FBS and were incubated with a fluorescently-labelled pan caspase inhibitor (FITC-VAD-
FMK, Calbiochem, San Diego, California) for 1 hour at 37oC. Samples were washed and 
resuspended in wash buffer, before immediate analysis by flow cytometry.  
All samples were acquired on Becton Dickinson FACSVantage flow cytometer (Mountain 
View, CA, USA) using CELLQuest Software. Appropriate isotype controls were used with each 




Lens release profile 
 
The release of OFX from contact lenses was characterized by absorbance. OFX – soaked 
lenses were incubated in 700 µL PBS for 24 hours at 37oC. The lens extracts were stored in glass 
vials at 4oC until analysis. Samples were transferred to quartz cuvettes, and absorbance was read on 
a UV spectrophotometer (Thermo MultiSkan Spectrum Photometer, Fischer Scientific, Ottawa, ON, 
Canada) in the range of 202 – 220 nm. Regression analysis was performed using Microsoft Excel.  
Statistical analysis 
All results are reported as means ± standard deviation (SD). To evaluate the significance of 
the differences in cell viability and cell activation, an ANOVA was carried out followed by a post 
hoc Bonferroni test using Statistica.  A p value of less than 0.05 was required for statistical 






Cell viability  
Cell viability was assessed after incubation periods of 24 hours. There was no observed 
difference between cells exposed to PBS-soaked lenses and cells cultured in the absence of a lens, 
indicating that it was not the presence of a lens that reduced cell viability; but rather the product 
released from the lens.  
For the dilutions tested, it was found that 10% OFX was significantly different from 1% and 
0.1% OFX (p < 0.002), while 5% OFX was only found to be significantly different from 0.1% (p = 
0.0273) (Figure 6.1). ReNu also demonstrated a significant concentration - dependent effect, where 
the 10% dilution was also significantly different from 0.1 and 1% ReNu (p < 0.00002). This finding 
was in contrast to Complete and Solo, which have the same disinfecting agent as ReNu. Both 
Complete and Solo did not adversely affect viability with increasing concentrations; at the 
maximum concentration tested, both solutions had around 80% viability. 
For the lens-solution combinations tested, LA-OFX was significantly different from all 
dilutions (p < 0.041), suggesting that the released OFX from LA lenses is either greater than 10% or 
modified in such a way, by LA, to be more cytotoxic to HCEC. OFX soaked GA, BA, CA and LB 
exhibited levels of viability similar to diluted OFX below 10%. In contrast to its interaction with 
OFX, ReNu soaked LA was found to have viability levels similar to the ones observed with ReNu at 






Figure 6.1: HCEC viability after 24 hour contact with various MPS in concentrations between 
0.10% and 10%. Viability was measured by MTT assay and is expressed as a percentage relative to 
cells grown in the absence of lenses. N = 4 to 6. * Significantly different from cells exposed to 10% 
dilution (p < 0.002), # Significantly different from cells exposed to 5% dilution (p < 0.03) 
Complete, Complete Moisture Plus; OFX, Opti-Free Express; OFR, Opti-Free RepleniSH; ReNu, ReNu 
MultiPlus; Solo, SoloCare Aqua  
 
A 50% reduction was seen with LA soaked in OFX (p = 0.0002), while LA-ReNu led to 
more than 30% reduction, which was significantly different from the positive PBS control (p = 
0.00006) (Figure 6.2). While there were similar trends in viability with all lenses, there was a 
significant difference in the viability of cells exposed to OFX at 24 hours. LA-OFX had 
significantly lower viability compared to BA, LB and CA lenses soaked in the same solution (p < 
0.01). Cells exposed to LB, GA and CA lenses soaked in OFX had levels similar to viability of BA, 
at 72, 61 and 71% viability after a 24 hour incubation time. These results demonstrate that lens type 
did have a significant effect on viability (p = 0.00000) and a significant interactive effect with 







Figure 6.2: HCEC viability after 24 hour contact with Lotrafilcon A (LA), Balafilcon A (BA), 
Lotrafilcon B (LB), Galyfilcon A (GA) and Comfilcon A (CA) soaked in various MPS. Viability 
was measured by MTT assay and is expressed as a percentage relative to cells grown in the absence 
of lenses. N = 4 to 6. # Significantly different for all lenses soaked in OFX from cells grown in the 
absence of lenses (p < 0.002). * Significantly different from cells grown in the absence of lenses (p 
< 0.002). 
Complete, Complete Moisture Plus; OFX, Opti-Free Express; ReNu, ReNu MultiPlus; Solo, SoloCare Aqua  
 
Table 6.3: P values of significance for effect of lens-solution combinations on cell viability. 
   Solo  OFX  Complete  ReNu 
LA  0.0017  0.000  1.00  0.000 
BA  0.00009  0.000  0.93  0.00006 
LB  1.00  0.0014  1.00  0.0886 
GA  1.00  0.000001 1.00  0.0033 
CA  0.0827  0.000001 1.00  0.1048 
 
Caspase activation 
Activated caspases were detected by flow cytometry. Cells were incubated with a 
fluorescently-tagged pan caspase inhibitor, which can bind to any and all activated caspases. The 
fluorescently-tagged pan caspase inhibitor fluoresced most intensely in cells with active caspases, as 







with LA lenses soaked in OFX, by detecting a significant amount of cells staining positive for 
caspases (p = 0.00000) (Figure 6.3). As in the viability results, BA-OFX was significantly better 
than LA-OFX (p = 0.002) and BA did not induce activation of caspases for any solution. In contrast, 
LB, GA and CA, had levels of caspase activation similar to LA-OFX (p = 1.000).  
 
Figure 6.3: HCEC caspase activation viability after 24 hour contact with Lotrafilcon A (LA), 
Balafilcon A (BA), Lotrafilcon B (LB), Galyfilcon A (GA) and Comfilcon A (CA) soaked in 
various MPS. Activation was measured by flow cytometry and is expressed as a percentage relative 
to cells grown in the absence of lenses. N = 4 to 6, * Significantly different from cells grown in the 
absence of lenses (p < 0.0006), # Significantly different from BA (p < 0.005).  
OFX, Opti-Free Express; OFR, Opti-Free RepleniSH; ReNu, ReNu MultiPlus; Solo, SoloCare Aqua  
 
Table 6.4: P values of significance for effect of lens-solution combinations on caspase activation. 
 
   Solo  OFX  OFR  ReNu 
LA  1.00  0.000  0.882  1.00 
BA  1.00  1.00  1.00  1.00 
LB  1.00  0.0005  1.00  1.00 
GA  1.00  0.0006  0.408  1.00 






With LB, GA and CA lenses soaked in OFX, a significant amount of cells staining positive 
for caspases was also detected, compared to cells grown in the absence of a lens (p < 0.0006). In 
addition, the level of caspase activation by CA-OFX was also significantly different from BA-OFX 
(p = 0.0041). These results demonstrate that lens type also have a significant effect on caspase 
activation (p = 0.000005) and a significant interactive effect with solution type (p = 0.00007).   
Lens release profile 
Both the MTT assay and caspase assay were sensitive enough to detect differences in release 
profiles of OFX from the tested silicone hydrogel lenses. Figure 6.4 illustrates the effect release of 
OFX from the various lenses can have on viability and caspase activation. 
    
Figure 6.4: HCEC caspase activation  and  viability after 24 hour contact with Opti-Free Express 
released from Lotrafilcon A (LA), Balafilcon A (BA), Lotrafilcon B (LB), Galyfilcon A (GA) and 
Comfilcon A (CA). Viability was measured by MTT assay and activation was measured by flow 



















The differences in cell viability and caspase activation may be due to the concentration of 
MPS released from the contact lens. A study on dilutions demonstrated that with increasing 
concentration of MPS, a greater adverse effect on HCEC viability was observed (Figure 6.1). In 
investigating the effect of dilutions on viability, one can estimate the potential release of MPS from 
contact lenses (Figure 6.5). Using the dilution data for each solution, a regression line was fitted to 
the data. The formula of the generated trendline was used to estimate the concentration of MPS 
released from contact lenses, given the viability observed using the MTT assay (Table 6.5). This 
method was able to estimate that LA-OFX, which has demonstrated decreased viability and 
increased apoptotic markers (previously discussed in Chapter 5), had released the equivalent of 
approximately 16% dilution onto the monolayer.  All other lenses released concentrations in the 
range of 5-10%. While the regressions for Solo and Complete generated concentrations in a similar 
range as LA-OFX, one must consider that the R-squared values are lower and statistical analysis 
revealed that there was no significant effect of concentration on viability. 
Integrin data also indicates that the concentration of OFX released from LA lenses is greater 
than 10%. It was observed that the expression of α3, β1 and β4 after exposure to LA-OFX was 
significantly lower than 10% OFX (p < 0.05), suggesting that LA lenses are releasing more than 
10%. The integrin data also suggests that for all other lens-solution combinations with LA and BA, 
the release is less than 10%. Findings with the pancaspase assay for LA-OFX also found that the 
release is likely to be greater than 10%. Results demonstrated that caspase activation was also 
concentration dependent, and showed an increase in cells staining positive for caspases, with 
increasing concentration of OFX. LA-OFX activated more caspases than both 5 and 10% OFX, 
























Figure 6.5: Concentration-dependent effect on viability. Regression analysis yielded trendline and formula for each 




Table 6.5: Approximation of concentration (%) released from contact lenses, given the viability. 
MTT Viability (%) 
   Solo  OFX  ReNu  Complete 
LA  70.91 47.87 66.60 87.75 
Conc. %  18.58 15.41 8.54 10.16 
BA  67.81 61.66 59.94 78.93 
Conc. %  21.21 9.88 10.70 21.33 
LB  87.40 72.15 77.95 96.35 
Conc. %  4.59 5.67 4.86 ‐0.74 
GA  84.60 60.86 71.92 93.56 
Conc. %  6.96 10.20 6.82 2.80 
CA  85.59 70.96 85.95 94.07 
Conc. %  6.12 6.15 2.26 2.15 
         
R squared  0.8598 0.9292 0.9769 0.4049 
 
A standard curve was also generated from the absorbance spectra of OFX dilutions. A peak 
in absorbance was observed at 206nm for all concentrations (Figure 6.6), therefore the standard 
curve was derived from the relative absorbance at this wavelength (Figure 6.7). A strong correlation 
was found, as indicated by the R-squared value of 0.9961.  
Lens extracts, diluted to 50%, were used to determine the concentration of MPS released 
(Figure 6.8); the given absorbance at 206nm was used in the regression analysis. In contrast to the 
previous predictions of OFX release, the lens release profile study using absorbance determined that 
the release of OFX from LA lenses is less than 2% (Table 6.6). For all other OFX combinations, the 
release characterized by absorbance spectra was found to be much less that the concentration 










Figure 6.7: Absorbance-concentration curve of OFX, at 206nm. Regression analysis yielded 
trendline and formula and was used to approximate OFX concentration released from contact lenses, 






Figure 6.8: Absorption spectra of lens extracts, diluted to 50%, after 24 hour incubation. 
 
Table 6.6: Approximation of concentration released from contact lenses, given the relative 
















The results obtained from cell contact with lenses soaked in phosphate buffer demonstrated 
near 100% viability and no change in caspase activation and thus confirmed the validity of our in 
vitro model. The major difference observed with the various lens-solution combinations was with 
BA-OFX. While it was similar in viability to LB, GA and CA, it was significantly different in terms 
of caspase activation. The BA-OFX combination was the only OFX combination that did not cause 
a significant increase in activated capases. The findings of this study can be explained in part by 
adsorption and release studies by Powell et al.11 They compared the sorption and release of Aldox, 
the active constituent of OFX and OFR, and PHMB, the active component of ReNu, Solo and 
Complete from various lenses. For both agents, LA and BA lenses had the greatest amount sorbed, 
but there was a much greater uptake of Aldox than PHMB. They also noted that Senofilcon A (not 
tested here), a silicone hydrogel with similar chemistry to GA, demonstrated high sorption rates. 
While the sorption rates were similar between these three lenses, the release profiles differed. Aldox 
was released rapidly from all lenses, with most release coming from LA lenses. This indicates that 
the high amount of sorbed Aldox on LA lenses was not tightly bound, thus releasing faster and to a 
greater degree than all other lenses.11 Conversely, BA lenses did not release Aldox in quantities as 
high as LA. Perhaps due to the surface heterogeneity and surface roughness of BA lenses9,10, Aldox 
was able to be sorbed tightly to the exposed hydrophobic material, thus only releasing to a lesser 
degree. The variable release of Aldox, a potentially cytotoxic agent, from SH lenses can explain the 
differences in viability and caspase activation demonstrated in this study. A greater release will 
expose cells to a higher concentration of the disinfecting agent, causing greater adverse events as 
demonstrated by the concentration dependent effect of OFX and ReNu. The most significant effects 




One must also consider the properties of the solutions, when looking at uptake and release 
profiles of contact lenses. In a recent drug uptake and release study,28 the authors concluded that if 
the uptake and release of a particular drug was only affected by material properties, then one would 
expect to see similar trends irrespective of drug or MPS tested. By demonstrating different trends in 
the Karlgard study,28 Powell study11 and the present study, it suggests that drug and MPS properties 
also can have an effect on the mechanism of uptake and release. While differences between Aldox 
and PHMB based solutions may be accounted for by differences in release profiles, a recent study30 
has shown that, unlike PHMB solutions, after interaction with lenses during the disinfection cycle 
OFX (and OFR) solution retains their bactericidal and fungicidal activity.30 While it is ideal to retain 
this property, it means that residual active disinfecting agents on lenses have the potential to interact 
adversely with the corneal surface. Additionally, the effect of dilutions also helps to illustrate this 
point. It was found that soluthe PHMB solutions, ReNu, Complete and Solo, had different effects 
with increasing concentrations, where ReNu had a significant concentration dependent effect 
whereas Complete and Solo did not. These findings likely indicate that there is not only the 
potential for interaction of the disinfecting agent with the lens, but also with other solution 
components. This additional interaction may account for the increased cytotoxicity in solutions with 
the same disinfecting agent. 
Several methods were used to characterize the release profile of lenses, to determine whether 
the concentration released could account for the difference between BA-OFX and all other 
combinations. Using dilutions, viability data was obtained for several concentrations and used to 
create a standard curve. Regression analysis was used to generate a trendline, which could 
determine the concentration released, given the viability as determined by MTT. Similarly, 




lens extract, the MPS concentration was determined. Contrasting results were obtained in the 
different methods used to approximate the release of MPS from contact lenses. The viability derived 
standard curve appeared to overestimate the release of MPS compared to the absorption spectra. It is 
possible that preferential adsorption and release by contact lenses may account for the difference. 
While it was determined by absorbance, that LA released less than 2% OFX, the composition of the 
solution being released is unknown. Since a greater effect on the cells is being observed, it would be 
expected that the lens extract would be largely composed of cytotoxic agents, due to the potential 
preferential adsorption or release. As previously discussed, the Powell study11 found that Aldox was 
released rapidly from LA lenses. While the cytotoxicity of Aldox is not known, this experiment 
demonstrates the ability of a lens to preferentially release certain agents from MPS after the 
disinfection cycle. Another possible explanation may be that the interaction of the lens may modify 
components of the solution to make them more cytotoxic. This would account for a greater 
cytotoxic effect at a lower concentration of release. This hypothesis is supported by the presence of 
an additional peak for LA-OFX around 230nm, which was not present the absorbance spectra of the 
diluted solution. This suggests there is an interaction of the lens and solution, which may result in 
modifications to the original components.   
In conclusion, the results from this study shows that for MPS-released from a contact lens, 
lens release profile can be investigated. As demonstrated by the absence of an effect on cells 
exposed to a PBS-soaked lens, our results indicate that it is not the presence of the lens that affects 
cell viability and phenotype, but what is being released from the lens. The in vitro model also 
demonstrated a lens effect in the mechanism of MPS-induced cell death pathways. The results 
indicate that OFX-induced cell death may be influenced by the surface treatment of certain SH 




the various ingredients in MPS, had a significant effect on viability and caspase activation. Further 
studies are underway to gain a better understanding of the preferential adsorption or release profile 
of certain compounds by silicone hydrogel lenses with different physical properties and surface 







CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE WORK 
 
The in vitro contact lens “onlay” model appears to be a valuable tool to study the direct 
release of multipurpose solutions on corneal epithelial cells.  In this thesis, the results indicate that a 
scale of cytotoxicity can be derived, among the commercially available MPS. The results obtained 
from cell contact with lenses stored in phosphate buffered packaging solution demonstrated 100% 
or near 100% viability and confirmed the validity of our in vitro model. As demonstrated by the 
absence of an effect on cells exposed to a PBS-soaked lens, our results indicate that it is not the 
presence of the lens that affects cell viability and phenotype, but what is being released from the 
lens.  
From the first chapter, Complete MPS demonstrated results similar to PBS, while OFX, 
ReNu and Solo demonstrated a significant adverse effect on viability and cell adhesion. 
Additionally, OFX demonstrated significant levels of caspase activation, indicating the possibility 
of a caspase-mediated cell death pathway. These in vitro studies demonstrated the following scale of 
corneal cell cytotoxicity: PBS < Complete < Solo < ReNu < OFX.  Our cytotoxicity scale is based 
on our results from MPS solutions released from contact lenses and is in accordance with previous 
studies where MPS was added directly to a monolayer of corneal cells. 
Studies on the mechanisms of cell death demonstrated that MPS-released from a contact lens 




solutions, OFX and ReNu, were induced by different mechanisms. OFX-induced cell death is a 
caspase mediated intrinsic apoptosis pathway, whereas the cell death induced by ReNu is necrosis.  
The in vitro model also demonstrated a lens effect in the mechanism of MPS-induced cell death 
pathways. The differences in physical properties of BA and LA lenses, which affect the uptake 
and/or release of the various ingredients in MPS, had a significant effect on viability, C3 activation 
and Annexin V/PI staining.  
The results from the lens material study showed that for MPS-released from a contact lens, a 
solution release profile from the lenses under examination can be determined. The in vitro model 
demonstrated a lens effect in cell viability and the mechanism of MPS-induced cell death pathways. 
The results indicate that OFX-induced cell death is affected by lenses with homogeneous surfaces.  
The differences in physical properties of lenses, which affect the uptake and/or release of the 
various ingredients in MPS, had a significant effect on viability and caspase activation. Further 
studies are under way to gain a better understanding of the preferential adsorption or release profile 
of certain compounds by silicone hydrogel lenses with different physical properties and surface 
treatments.  
Future work should focus on identifying the components of MPS suspected of being 
cytotoxic agents. This can be accomplished through the use of custom multipurpose solutions, 
where the concentrations of the preservatives can be varied, to determine concentration dependent 
effect and custom combinations of preservatives and buffering agents, which are not commercially 
available (i.e. Polyquad®/Aldox® with phosphate buffer compared to borate buffer). This would 
help to isolate the agent of MPS responsible for inducing apoptotic cell death and determine if there 




a control should be considered, given its presence as a preservative in a wide range of ocular durgs 
and solutions.  
Further work is also required to characterize the lens/solution release profile. Different 
methods, such as FTIR analysis, are currently being considered for use in identifying and 
quantifying different components of MPS in lens extracts. These methods will also aid in 
determining whether components of MPS are being modified after interaction with contact lenses in 
the overnight disinfection cycle. Additionally, the use of stratified cultures on curved surfaces can 
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